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Abstract
In this article, we analyze the morphometry (shape and size) of hippocampus in subjects with very mild
dementia of Alzheimer’s type (DAT) and nondemented controls and how the morphometry changes over
a two-year period. Morphometric differences with respect to a template hippocampus were measured
by the metric distance obtained from the Large Deformation Diffeomorphic Metric Mapping (LDDMM)
algorithm which was previously used to calculate dense one-to-one correspondence vector fields between
the shapes. LDDMM assigns metric distances on the space of anatomical images thereby allowing for
the direct comparison and quantization of morphometric changes. We characterize what additional in-
formation the metric distances provide in terms of size and shape given the volume measurements of the
hippocampi. Moreover, we demonstrate how metric distances can be used in cross-sectional, longitudinal,
and left-right asymmetry comparisons. We perform a principal component analysis on metric distances
and hippocampus, brain, and intracranial volumes. We use repeated measures ANOVA models to test
the main effects of and interaction between the diagnosis, duration, and hemisphere factors to see which
factors significantly explain the differences in metric distances. When a factor is found to be significant,
we use classical parametric and non-parametric tests to compare the metric distances for that factor. The
analysis of metric distances is then used to compare the effects of aging in the hippocampus. At base-
line, the metric distances for demented subjects are found not to be significantly different from those for
nondemented subjects. At follow-up, the metric distances for demented subjects were significantly larger
compared to nondemented subjects. The metric distances for demented subjects increased significantly
from baseline to follow-up but not for nondemented subjects. We also demonstrate that metric distances
can be used in a logistic regression model for diagnostic discrimination of subjects. We compare metric
distances with the volumes and obtain similar results in cross-sectional and longitudinal comparisons. In
classification, the model that uses volume, metric distance, and volume loss over time together performs
better in detecting DAT. Thus, metric distances with respect to a template computed via LDDMM can
be a powerful tool in detecting differences in shape in cross-sectional as well as longitudinal studies.
1 Introduction
Numerous post-mortem studies have shown that neurofibrillary tangles and amyloid plaques characteristic
of Alzheimer’s Disease (AD) are prominent within the hippocampus of individuals with mild dementia of
the Alzheimer’s type (DAT) and that the distribution of these neuropathological markers becomes more
widespread to include several regions of the neocortex as the disease process progresses [1-7]. The accumulation
of neurofibrillary tangles and amyloid plaques characteristic of AD are associated with neuronal damage and
death [8]. Furthermore, macroscopic gray matter losses from the accumulation of microscopic scale neuronal
destruction are detectable in living subjects using currently available magnetic resonance (MR) imaging.
Specifically, volume losses within the hippocampus [9-14] have recently been reported in subjects with mild-to-
moderate AD. In an unusual study where the antemortem MR scans and post-mortem material was available
for the same subjects, hippocampal volume losses were shown to be powerful antemortem predictors of AD
neuropathology [15]. Progressive atrophy of the entire brain has been observed in AD cases [16]. However,
due to the complexity of the human brain and the non-uniform distribution of AD neuropathology early in
the course of disease, detailed examination of specific brain regions known to be affected early in the AD
disease process (e.g., hippocampus) may be preferred for distinguishing preclinical and very mild forms of AD
from normal aging [17-19].
Methods developed in the field of Computational Anatomy (CA) that enable quantification of brain struc-
ture volumes and shapes between and within groups of individuals with and without various neurological
diseases have emerged from several groups in recent years [20-25]. Based on the mathematical principles of
general pattern theory [18, 19, 23, 26, 27], these methods combine image-based diffeomorphic maps between
MR scans with representations of brain structures as smooth manifolds. Because of their high repeatability
and sensitivity to changes in neuroanatomical shapes, they can be especially sensitive to abnormalities of
brain structures associated with early forms of AD. Using such methods, we previously demonstrated that
the combined assessment of hippocampal volume loss and shape deformity optimally distinguished subjects
with very mild DAT from both elder nondemented subjects and younger healthy subjects [10]. These methods
also allowed us to demonstrate that hippocampal shape deformities associated with very mild DAT and non-
demented aging were distinct [28]. These methods were also extended to quantify changes in neuroanatomical
volumes and shapes within the same individuals over time [29]. Other longitudinal neuroimaging analysis of
hippocampal structures in individuals with AD have also emerged [30-41].
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An important task in CA is the study of neuroanatomical variability. The anatomic model is a quadruple
(Ω,G, I,P) consisting of Ω the template coordinate space (in R3), defined as the union of 0, 1, 2, and 3-
dimensional manifolds, G : Ω ↔ Ω a set of diffeomorphic transformations on Ω, I the space of anatomies is
the orbit of a template anatomy I0 under G, and P the family of probability measures on G. In this framework,
a geodesic φ : [0, 1]→ G is computed where each point φt ∈ G, t ∈ [0, 1] is a diffeomorphism of the domain Ω.
The evolution of the template image I0 along path is given by φtI0 = I0 ◦ φ
−1
t such that the end point of the
geodesic connects the template I0 to the target I1 via I1 = φ1I0 = I0 ◦ φ
−1
1 . Thus, anatomical variability in
the target is encoded by these geodesic transformations when a template is fixed.
Furthermore, geodesic curves induce metric distances between the template and the target shapes in the
orbit as follows. The diffeomorphisms are constructed as a flow of ordinary differential equations φ˙t = vt(φt),
t ∈ [0, 1] with φ0 = id the identity map, and associated vector fields, vt, t ∈ [0, 1]. The optimal velocity
vector field parameterizing the geodesic path is found by solving
v̂ = arg inf
v : φ =
∫ 1
0
vt(φt)dt,
φ0 = id
∫ 1
0
‖vt‖
2
V dt such thatI0 ◦ φ
−1
1 = I1, (1)
where vt ∈ V , the Hilbert space of smooth vector fields with norm ‖·‖V defined through a differential operator
enforcing smoothness. The length of the minimal length path through the space of transformations connecting
the given anatomical configurations in I0 and I1 defines a metric distance between anatomical shapes in I0
and I1 via
d(I0, I1) =
∫ 1
0
‖v̂t‖V dt, (2)
where v̂t is the optimizer calculated from the Large Deformation Diffeomorphic Metric Mapping (LDDMM)
algorithm [42]. Here, the metric distance does not have any units. The construction of such a metric space
allows one to quantify similarities and differences between anatomical shapes in the orbit. This is the vision
laid out by D’Arcy W. Thompson almost one hundred years ago. Figure 1 exemplifies the change in the
metric distance during the evolution of the diffeomorphic map from the template shape to the target shape.
The notion of mathematical biomarker in the form of metric distance can be used in different ways.
One is to generate metric distances of shapes relative to a template [42, 43]. Another is to generate metric
distances between each shape within a collection [44]. The latter approach allows for sophisticated pattern
classification analysis; it is however computationally expensive. We present an analysis based on the former
approach which could provide a powerful tool in analyzing subtle shape changes over time with considerably
less computational load. This approach may allow detecting the subtle morphometric changes observed in the
hippocampus in DAT subjects in particular for those previously analyzed [29, 45]. These studies compared
rates of change in hippocampal volume and shape in subjects with very mild DAT and matched (for age
and gender) nondemented subjects. The change in hippocampal shape over time was defined as a residual
vector field resulting from rigid-body motion registration, and changes in patterns along hippocampal surfaces
were visualized and analyzed via a statistical measure of individual and group change in hippocampal shape
over time and used to distinguish between the subject groups. Hence the motivation to analyze LDDMM
generated metric distances between binary hippocampus images at baseline and at follow-up with respect
to the same template hippocampus image. That is, the template was compared again, and not propagated
between time points. One might wonder why we do not track changes within a subject directly, rather than
via a reference template, as it could give a more sensitive measure of shape change since the small difference
in shape would make finding correspondence more accurate. Although we have considered doing this, the
difficulty is that since the template (or origin) is different for each longitudinal computation, how to correctly
perform statistical comparison of group change is not completely settled. This is actively being developed by
using the concept of “parallel transport” [46, 47]. In this study, we compute and analyze metric distances
based on the data used in [29].
We briefly describe the data set in Section 2.1, computation of metric distances via LDDMM in Section 2.2,
statistical methods we employ in Section 2.3, and results and findings in Section 3, which include descriptive
summary statistics of the metric distances, comparison of metric distances of hippocampi of non-demented
subjects and subjects with very mild dementia, correlation between metric distances, comparison of distri-
butions of metric distances, and discriminative power of metric distances. We perform similar analysis on
hippocampal volumes in Section 4, compare volumes and LDDMM distances in Section 5, and analyze annual
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percentage rate of change in volumes and distances in Section 6. In the final section, we discuss the use of
metric distances for baseline-followup studies, group comparisons, and discrimination analysis.
2 Methods
2.1 Subjects and Data Acquisition
Detailed description of subjects can be found in [29] where 18 very mild DAT subjects (Clinical Dementia
Rating Scale, CDR0.5) and 26 age-matched nondemented controls (CDR0) were each scanned approximately
two years apart. Clinical Dementia Rating (CDR) Scale assessments which detect the severity of dementia
symptoms were performed annually in all subjects by experienced clinicians without reference to neuropsy-
chological tests or in-vivo neuroimaging data. The experienced clinician conducted semi-structured interviews
with an informant and the subject to assess the subject’s cognitive and functional performance; a neurologi-
cal examination was also obtained. The clinician determined the presence or absence of dementia and, when
present, its severity with the CDR. Overall CDR scores of 0 indicate no dementia, while CDR scores of 0.5,
1, 2, and 3 indicate very mild, mild, moderate and severe dementia, respectively [48]. CDR assessments have
been shown to have an inter-rater reliability of κ = 0.74 (weighted kappa coefficient [49] κ of 0.87) [50], and
this high degree of inter-rater reliability has been confirmed in multi-center dementia studies [51]. Elderly
subjects with no clinical evidence of dementia (i.e., CDR0 subject) have been confirmed with normal brains
at autopsy with 80% accuracy; i.e., approximately 20% of such individuals show evidence of AD [52]. CDR0.5
subjects have subtle cognitive impairment, and 93% of them progress to more severe stages of illness (i.e.,
CDR > 0.5) and show neuropathological signs of AD at autopsy ([53], [54], and [52]). Although elsewhere
the CDR0.5 individuals in our sample may be considered to have MCI [55], they fulfill our diagnostic criteria
for very mild DAT and at autopsy overwhelmingly have neuropathologic AD [56]. A summary of subject
information is listed in Table 1.
The scans were obtained using a Magnetom SP-4000 1.5 Tesla imaging system, a standard head coil, and a
magnetization prepared rapid gradient echo (MPRAGE) sequence. The MPRAGE sequence (TR/TE - 10/4,
ACQ - 1, Matrix - 256 × 256, Scanning time - 11.0 min) produced 3D data with a 1mm × 1mm in-plane
resolution and 1 mm slice thickness across the entire cranium.
A neuroanatomical template was produced using an MR image from an additional elder control (i.e.,
CDR0 or non-demented) subject (male, age = 69). The choice and a detailed description of the template is
provided in [57]. The subject selected to produce this template was obtained from the same source as the
other subjects in the study, but was not otherwise included in the data analysis. Data used are the left and
right hippocampal surfaces in the template scan created from expert-produced manual outlines using methods
previously described [28,58], and the left and right hippocampal surfaces of each subject generated at baseline
and follow-up. These surfaces were converted to binary hippocampus volumetric images by flood filling the
inside of the surface and giving it label 1, and the outside of the surface was labeled as 0, or background. Each
individual hippocampal surface was first scaled by a factor of 2 and aligned with the template surface, which
was also scaled by a factor of 2, via a rigid-body rotation and translation before converting to volumetric
binary images. In [58] we showed that mapping accuracy could be enhanced at higher resolution because of
smaller voxels – voxels at the periphery of the structure (i.e., surface) account for much more of the structural
volume at 1 mm3 voxel resolution versus 0.5 mm3. Since then we have adapted this as part of the standard
mapping procedure. These surfaces were then converted into binarized image of dimension 64 × 112 × 64
with voxel resolutions of 0.5× 0.5 × 0.5 mm3, followed by smoothing by a Gaussian filter of 9 × 9 × 9-voxel
window and one voxel standard deviation to smooth out the edges for LDDMM, which was then applied to
each template-subject pair to compute metric distances, dbk, d
f
k(k = 1, . . . , 44), in each hemisphere at baseline
(b) and at follow-up (f) as illustrated in Figure 2.
Controlling for brain size is important because people with bigger brains tend to have bigger hippocampus
and we want our results to not reflect that very uninteresting fact; we inherently correct for brain size by first
rigid-aligning the subject brain to the prototype brain prior to LDDMM. Segmentation of hippocampal MRI
shapes across subjects, especially in diseased states, is a challenging problem. However the accuracy of the
segmentation is not the point of this paper and has been demonstrated before [10, 57, 58].
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In addition to the metric distances, our data set also consists of the following variables: gender, age, educa-
tion in years (these variables are used for controlling the confounding affects of these factors on hippocampus
morphometry, so the subjects are taken to be similar or evenly distributed in these variables). Furthermore,
we have brain and intracranial volumes at baseline and followup, and hippocampus volumes for left and right
hippocampi at baseline and follow-up.
2.2 Computing Metric Distance via Large Deformation Diffeomorphic Metric
Mapping
Metric distances between the binary images and the template image are obtained by computing diffeomor-
phisms between the images. Computation and analysis of these diffeomorphic mappings have been previously
described [57]. Diffeomorphisms are estimated via the variational problem that, in the space of smooth
velocity vector fields V on domain Ω, takes the form [42]:
v̂ = argmin
v:φ˙t=vt(φt)
(∫ 1
0
‖vt‖
2
V dt+
1
σ2
∥∥I0 ◦ φ−11 − I1∥∥2L2
)
. (3)
The optimizer of this cost generates the optimal change of coordinates ϕ = φbv1 upon integration d φ̂
v
t
/
dt =
v̂t
(
φ̂
v
t
)
, φ0 = id, where the subscript v in φ
v is used to explicitly denote the dependence of φ on the associated
velocity field v. Enforcing a sufficient amount of smoothness on the elements of the space V of allowable
velocity vector fields ensures that the solution to the differential equation φ˙t = vt(φt), t ∈ [0, 1], vt ∈ V is
in the space of diffeomorphisms [59, 60]. The required smoothness is enforced by defining the norm on the
space V of smooth velocity vector fields through a differential operator L of the type L = (−α∆+ γ)αIn×n
where α > 1.5 in 3-dimensional space such that ‖f‖V = ‖Lf‖L2 and ‖·‖L2 is the standard L2 norm for square
integrable functions defined on Ω. The gradient of this cost is given by
∇vEt = 2 v̂t−K
(
2
σ2
∣∣∣Dφbvt,1∣∣∣∇J0t (J0t − J1t )
)
(4)
where J0t = I0 ◦ φt and J
1
t = I1 ◦ φ
−1
t , |Dg| is the determinant of the Jacobian matrix for g and K is a
compact self-adjoint operator K : L2
(
Ω,Rd
)
→ V uniquely defined by < a, b >L2=< Ka, b >V such that for
any smooth vector field f ∈ V , K(L†L)f = f holds. The metric distance is then calculated via Equation (2).
2.3 Statistical Methods
First, we investigate what LDDMM metric distance measures and how it is related to hippocampus, brain,
and intracranial volumes. That is, as a compound measure of morphometry, how much of the metric distance
is related to shape and size and how it is associated with the volume, which is mostly a measure of size. Along
this line, we provide the correlation between volume and metric distance measures by the pairs plots at baseline
and follow-up of left and right hippocampi. Furthermore, we perform a principal component analysis (PCA)
on metric distance and volumes to characterize the major traits these quantities measure. Then we provide
a statistical methodology for the analysis of LDDMM distances. We compute and interpret simple summary
statistics, such as, mean, standard deviation (SD), minimum, first quartile (Q1), median, third quartile (Q3),
and maximum for d
{b,f}
k . Then we apply repeated measures analysis of metric distances with diagnosis group
as main effect and timepoint as the repeated factor, side (i.e., hemisphere) as main effect and timepoint as
the repeated factor, and diagnosis group as main effect and side-by-timepoint as the repeated factor, since
there are within-subject dependence of metric distances for left and right hemispheres and at baseline and
follow-up. We apply four possible competing models each assuming a different variance-covariance structure
to obtain the model that best fit to our data set. The first model assumes compound symmetry, in which the
diagonals (i.e., the variances) are equal, and so are the off diagonals (i.e., the covariances). The other three
models assume unstructured, autoregressive (AR), and autoregressive heterogeneous variances, respectively.
In the unstructured model, each variance and covariance term is different, in the AR model, the variances
are assumed to be equal but the covariances change by time, and in the ARH model, the variances are also
different and the covariances change by time. The corresponding variance-covariance (Var-Cov) structures
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[61-63] for the models are shown in Table 5, where σ2 is the common variance term, σ2i is the variance for
repeated factor i, σij is the covariance between repeated factors i and j, and ρ is the correlation coefficient of
first order in an autoregressive model. We use various model selection criteria (Akaike Information Criterion
(AIC), Bayesian Information Criterion (BIC), Log-likelihood) to compare competing models to see which
model best fits our data [64].
For post-hoc comparison of CDR0.5 vs CDR0, our null hypothesis for the comparison of diagnosis groups,
CDR0 and CDR0.5, is Ho : µCDR0 = µCDR0.5 for each baseline left, baseline right, and follow-up left, follow-
up right hippocampi. For the t-test, among the underlying assumptions are the normality of the distributions
and homogeneity of the variances of the independent samples. We employ Lilliefor’s test of normality [65];
and Brown and Forsythe’s (B-F) test (i.e., Levene’s test with absolute deviations from the median) for
homogeneity of the variances [66]. If there is lack of significant deviation from normality of distribution of a
metric distances for a group, we will state it as “the metric distances for the group can be assumed to come
from a normally distributed population”, henceforth.
We compare metric distances at baseline and follow-up. The LB-CDR0.5 metric distances and LF-CDR0.5
metric distances are dependent as they come from the same person at baseline and follow-up. Likewise for
LB-CDR0 and LF-CDR0 pairs. Hence our null hypothesis for the comparison of baseline and follow-up groups
is Ho : δ(B,F ) = 0 where δ(B,F ) is the mean difference of metric distances between hippocampi at baseline
and follow-up for each of CDR0 left, CDR0 right, CDR0.5 left, CDR0.5 right hippocampi. We also compare
the metric distances for the left and right hippocampi are dependent (for each left-right hippocampi pair
comes from the same subject). Hence our null hypothesis for the comparison of left and right metric distances
is Ho : δ(L,R) = 0 where δ(L,R) is the mean difference of metric distances between left and right metric
distances for each of CDR0 baseline, CDR0 follow-up, CDR0.5 baseline, CDR0.5 follow-up hippocampi.
We also calculate and interpret correlation coefficients between metric distances. Since metric distances of
all groups can be assumed to have normal distribution based on Lilliefor’s test of normality, we use Pearson’s
correlation coefficient, denoted rP , between baseline and follow-up (overall and by diagnosis group) and for
the left and right hippocampi and the corresponding tests of Ho : rP = 0 vs Ha : rP > 0 for inference
[67,68].
We also estimate the empirical cumulative distribution functions (cdf) of the metric distances and compare
them by Kolmogorov-Smirnov (K-S) test, Crame´r’s test, and Crame´r-von Mises test. The null hypothesis for
the comparison of cdfs of the metric distances per diagnosis groups, CDR0 and CDR0.5, is Ho : FCDR0 =
FCDR0.5 for each baseline left, baseline right, follow-up left, follow-up right hippocampi. For calculation of
the critical value of Crame´r’s test the kernel φC(x) =
√
x
2 (which is recommended for location alternatives) is
used. The estimated p-values are based on α = 0.05 and 10000 ordinary bootstrap replicates.
We apply logistic discrimination with metric distances and other variables, since the diagnosis have only
two levels, namely CDR0 and CDR0.5. We use logistic regression to estimate or predict the risk or probability
of having DAT using metric distances, together with side (i.e., hemisphere) and timepoint (baseline vs follow-
up) factors. In other words, we model the probability that the subject is CDR0.5 given the metric distance
of the subject for left or right hippocampus at baseline or follow-up. In standard logistic regression the
model-parameters are obtained via maximum likelihood estimators. For more on logistic regression and
logistic discrimination, see [69] and [70], respectively. We consider the logistic model with the response
where (i.e., the probability that the subject is diagnosed with CDR0.5). First we model with one predictor
variable at a time from side, timepoint, and metric distance, etc., if the variable is not significant at .05
level, we omit that variable from further consideration. We consider the full logistic model with the response
logit p = log [p/(1− p)] where p = P (Y = 1) (i.e., the probability that the subject is diagnosed with CDR0.5);
the remaining variables with all possible interactions as the predictor variables. On this full model, we choose
a reduced model by AIC in a stepwise algorithm, and then use stepwise backward elimination procedure on
the resulting model [64]. We stop the elimination procedure when all the remaining variables are significant
at α = 0.05 level.
Based on the final model with significant predictors, we apply logistic discrimination. In logistic discrimi-
nation the log-odds-ratio of the conditional classification and therefore indirectly the conditional probabilities
of being CDR0.5 and CDR0 are modeled. In general, if this estimated probability is larger than a prespecified
probability po, the subject is classified as CDR0.5, otherwise the subject is classified as CDR0 (i.e., normal).
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This means our decision function reduces to
p̂k = P (Y = 1|dijk)
{
> po ⇒ classify CDR0.5,
≤ po ⇒ classify CDR0,
(5)
where po is usually taken to be 0.5. This threshold probability po can also be optimized with respect to a
cost function which incorporates correct classification rates, sensitivity, and/or specificity [71].
We apply the same analysis procedure on hippocampal volumes to compare the results with LDDMM
metric distances. Furthermore, we find the differential volume loss and metric distance change by using the
annual percentage rate of change (APC) in volume and metric distance (see [71] for APC in volume for
entorhinal cortex). We also consider the logistic discrimination models that incorporate volume and metric
distance together and APC in volumes and metric distances together.
3 Analysis of LDDMM Distances of Hippocampi
3.1 Preliminary Analysis of LDDMM Distances and Other Variables
The summary measures for the variables are provided in Table 1. Observe that the subjects are evenly
distributed in terms of gender, years of education, scan intervals, and age for the diagnostic groups. The
brain and intracranial volumes are much larger in scale, then come the hippocampal volumes, and then the
metric distances. Notice that brain and hippocampal volumes all decrease by time and are smaller in CDR0.5
subjects compared to CDR0 subjects. On the other hand, the metric distances tend to increase by time and
are larger for the CDR0.5 subjects. Also presented in Table 1 are the p-values for Lilliefor’s test of normality
and Wilcoxon rank sum test for differences between the diagnostic groups. Notice that most variables can
be assumed to follow a Gaussian distribution, but since a few fails to do so, we apply the Wilcoxon rank
sum test instead of Welch’s t-test. The diagnostic groups do not significantly differ in age, education, brain
and intracranial volumes. Furthermore, among the metric distances, we see that only right follow-up metric
distances are significantly different between the diagnostic groups.
We present the pairs plot (scatter plot of each pair) of continuous variables in Figure 3 and also calculate
the correlation coefficients between each pair of the variables (not presented). We observe that age and
education are not significantly correlated with any of the other variables. Hence we discard them in our
prospective analysis (except for logistic discrimination). We observe significant correlation between each pair
of hippocampal volumes, and between each pair of brain and intracranial volumes. The metric distances
are only moderately correlated with each other. Hippocampal volumes are mildly correlated with brain and
intracranial volumes. The same holds for the metric distances but to a lesser extent.
Summary statistics of population mean, standard deviation (SD), minimum, first quartile (Q1), median,
third quartile (Q3), and maximum for d
{b,f}
k are presented in Table 1.
Baseline metric distances seem to be different in distribution (location and spread) from follow-up metric
distances follow-up distances being larger than baseline distances for both left and right hippocampi; likewise
left metric distances seem to be different from right metric distances with right distances being larger than
left for both baseline and follow-up. Let LDB be the metric distances for left hippocampi at baseline, LDF
be the metric distances for left hippocampi at follow-up. Let RDB and RDF be similarly defined for right
hippocampi. One-tailed t-tests revealed that the order of these measures is LDB < LDF < RDB < RDF with
all inequalities being significant at .05 level. This implies that the morphometric differences of left hippocampi
with respect to the left hippocampus of the template subject at baseline are significantly smaller than those
at follow-up, i.e., at baseline, left hippocampi are more similar to the left template hippocampus, and by
follow-up left hippocampi tend to become more different in morphometry (shape and size) from the template
hippocampus. This is not surprising, as the template hippocampus is one from the baseline hippocampi. That
is the template was based on a baseline scan. Although this should seem to be irrelevant in view of the wide
age variation, it is not the age that is the main point here, when baseline and follow-up are compared, we use
matched pair (i.e., dependent) tests, which would reveal differences that would otherwise be concealed by the
independent two-sample tests. For example, when all the subjects age about two years, their morphometric
alterations accumulate to render their relative difference from the template more significant.
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The right hippocampi reveal similar morphometric differences and change over time. Furthermore, we
observe that the morphometric difference of right hippocampi from the right template hippocampus is sig-
nificantly larger compared to the morphometric difference of left hippocampi from the left template at both
baseline and follow-up. The summary statistics (means and standard deviations (SD)) for left and right
metric distances by group are provided in Table 1.
Observe that CDR0 distances are smaller than CDR0.5 distances at baseline and at follow-up for both left
and right hippocampi. This suggests that the morphometric differences of CDR0 hippocampi with respect to
the template hippocampus are smaller than those of CDR0.5 hippocampi. This is not surprising, considering
the template hippocampus being one of the CDR0 hippocampi. Furthermore, the standard deviations of the
distances for CDR0 subjects tend to be smaller than those of CDR0.5 subjects. That is, the morphometric
variability of CDR0 hippocampi with respect to the template hippocampus is smaller than that of CDR0.5
hippocampi. The statistical significance of these results will be provided in the following sections.
See also Figure 4 for the (jittered) scatter plots of the metric distances by group, where the crosses are
centered at the mean distances and the points are jittered (scattered) along the horizontal axis in order to avoid
frequent point concurrence and tight clustering of points, thereby making the plot better for visualization.
3.2 Principal Component Analysis for the Volumes and Metric Distances
The volumes and metric distances measure different but related aspects of morphometry, so some of the
variables are highly correlated with each other (see Figure 3). We perform principal component analysis
(PCA) to obtain a set of uncorrelated variables that hopefully represent some identifiable aspect of the
morphometry. See [70,76] for more on PCA. When we perform PCA of metric distances and volumes of left
hippocampi at baseline with eigenvalues based on the covariance matrix, we observe that the first principal
component (PC) accounts for almost all the variation (see Table 2). Considering the variable loadings in
Table 2, we see that PC1 is the head size component, PC2 is the contrast between brain and intracranial
volumes, PC3 is the hippocampus size, and PC4 is the metric distance component. However, the volumes
are in mm3 and metric distances are unitless, hence the data are not to scale. In particular, the brain and
intracranial volumes have the largest variation in the data set, hence dominate the PCs. To remove the
influence of the scale (or unit), we apply PCA with eigenvalues based on the correlation matrix (i.e., PCA on
the standardized variables). The importance scores of principal components and variable loadings from the
PCA of metric distances and volumes of left hippocampi at baseline and followup with eigenvalues based on
the correlation matrix are presented in Table 3. Notice that with the correlation matrix, the first three PCs
account for almost all the variation in the variables. Comparing the variable loadings, PC1 seems to be the
head size component, PC2 is the hippocampus shape, PC3 is the hippocampus size and the contrast between
hippocampus and head size, and PC4 is the contrast between brain and intracranial volume. The PCA on
variables for right hippocampi yields similar results (see Table 4).
The variable loadings in the PCA of variables at baseline and follow-up suggest that brain and intracra-
nial volumes are mostly measures of head size, metric distance is mostly a measure of hippocampus shape
and partly is a measure of head and hippocampus size, and hippocampus volume is mostly a measure of
hippocampus size and partly related to hippocampus shape and head size. That is, volumes and the metric
distance convey information that is related but not identical. Volumes mostly emphasize the size differences,
while metric distances emphasize the shape differences. Hence, one should use both of them in morphometric
analysis of brain tissues.
3.3 Repeated Measures Analysis of LDDMM Distances
Due to within-subject dependence of metric distances for left and right hemispheres and for baseline and
follow-up measures, we apply repeated-measures analysis with group and side as main effects and timepoint
as the repeated factor, and group as main effect and side-by-timepoint as the repeated factor (see below).
For the left data, metric distances at baseline for CDR0.5 subjects are labeled as LB-CDR0.5, at follow-up
are labeled as LF-CDR0.5. CDR0 individuals are labeled as LB-CDR0 and LF-CDR0 accordingly. Similar
labeling is done for the right metric distances. Hence, we have four measurements for each subject, so repeated
measures analysis can be performed on our data set.
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3.3.1 Modeling LDDMM Distances with Group as Main Effect with Compound Symmetry in
Var-Cov Structure
For the repeated measures ANOVA with group as main effect and compound symmetry repeated over time,
for each subject, we will denote diagnosis, timepoint, and hemisphere factors as numerical subscripts for
convenience. The corresponding model is
dijk = µ+ α
D
i + α
T
j + α
DT
ij + εijk (6)
where dijk is the distance for subject k with diagnosis i (i = 1 for CDR0; 2 for CDR0.5) at timepoint j
(j = 1 for baseline; 2 for follow-up), µ is the overall mean, αDi is the effect of diagnosis level i, α
T
j is the
effect of timepoint level j, αDTij is the diagnosis-by-timepoint interaction, i.e., part of the mean distance
not attributable to the additive effect of diagnosis and timepoint, and εijk is the error term. The Var-Cov
structure for the error term is
Var(εijk) = σ
2 and Cov(εijk, εij′k) = σ
T
1 .
Notice that the effect of side (left or right) is ignored in this model. There is no significant group main effect
(F = 3.36, df = 1, 42, p = 0.0739). However, the within group time-point main effect (F = 11.16, df =
1, 130, p = 0.0011) and the group-by-timepoint interaction (F = 4.84, df = 1, 130, p = 0.0295) are both
significant, which imply that the two groups should be compared at the different time points. In Figure 5, we
present the interaction plots for diagnosis over time, where the end points of the line segments are located at
the mean metric distances at baseline and follow-up years. We see that both lines increase over time, but are
not parallel; the increase of the line for CDR0.5 group is steeper.
3.3.2 Modeling LDDMM Distances with Side as Main Effect with Compound Symmetry in
Var-Cov Structure
For the repeated measures ANOVA with side as main effect and compound symmetry repeated over time,
the corresponding model is
dijk = µ+ α
S
i + α
T
j + α
ST
ij + εijk (7)
where dijk is the distance for subject k for side i (i = 1 for left; 2 for right) at timepoint j (j = 1 for baseline;
2 for follow-up), µ is the overall mean, αSi is the effect of side level i, α
T
j is the effect of timepoint level j, α
ST
ij
is the side-by-timepoint interaction, and εijk is the error term. The Var-Cov structure for the error term is
Var(εijk) = σ
2 and Cov(εijk, εij′k) = σ
T
1 .
Notice that the effect of diagnosis (CDR0 or CDR0.5) is ignored in this model. The side and timepoint main
effects are both significant (F = 20.25, df = 1, 129,p < 0.0001andF = 12.51, df = 1,129, p = 0.0006, respec-
tively), but side-by-timepoint interaction is not significant (F = 1.85, df = 1,129, p = 0.1766). Consequently,
we see that the lines are parallel but far apart, the main effect of side comparison is meaningful and about
the same at each timepoint. Moreover, the sides do change in morphometry over time. In Figure 5, we see
that both lines increase over time and are parallel, but the slope for right side seems to be steeper, which will
eventually make the slope estimates significantly different.
3.3.3 Modeling LDDMM Distances with Group, Side, and Group-by-Side Interaction
Looking at models including only the main effects of side or group separately does not answer all our questions.
We would also like to know, for example, if the metric distances of left hippocampi of CDR0.5 subjects are
different from those of left CDR0 subjects. In order to address these types of questions we need to look at a
model that includes the interaction of diagnosis and side. First, we need to model the Var-Cov structure for
the repeated measures for each subject. We have four correlated measures per subject, namely LDB, LDF,
RDB, and RDF. Below is the estimated Var-Cov matrix for these variables:

0.46 0.35 0.18 0.02
0.35 0.60 0.24 0.18
0.18 0.24 0.45 0.23
0.02 0.18 0.23 0.44


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We start with compound symmetry for our model, and then try unstructured, autoregressive (AR), and au-
toregressive heterogeneous (ARH) Var-Cov structures. The variances (in the diagonal) suggest heterogeneity
between them, and also, covariances seem to differ. This suggests that either an unstructured or ARH model
might fit this data best. See Table 6 for the comparison of model selection criteria such as AIC, BIC, and
Log-likelihood and likelihood ratio test p-value.
The most promising model is the unstructured model based on likelihood ratio test, since -2 Log Likelihood
scores are significantly smaller than the -2 Log Likelihood scores of other models. However, BIC and AIC favor
the model with the AR variance-covariance structure. Besides, the log-likelihood approach gives the second
smallest -2 Log Likelihood score for this model. Hence, we choose the model with AR Var-Cov structure.
The corresponding model is
dijkl = µ+ α
S
i + α
D
j + α
T
k + α
SD
ij + α
ST
ik + α
DT
jk + α
SDT
ijk + εijkl, (8)
where dijkl is the distance for subject l for side i (1 for left; 2 for right) with diagnosis j (j = 1 for CDR0; 2
for CDR0.5) at timepoint k (k = 1 for baseline; 2 for follow-up), µ is the overall mean, αSi is the effect of side
level i, αDj is the effect of diagnosis level j, α
T
k is the effect of timepoint level k, α
SD
ij is the side-by-diagnosis
interaction, αSTik is the side-by-timepoint interaction, α
DT
jk is the diagnosis-by-timepoint interaction, α
SDT
ijk
is the side-by-diagnosis-by-timepoint interaction, and εijkl is the error term. The Var-Cov structure for the
error term is
Cov(εijkl , εi′jk′l) =


σ2
σρ σ2
σρ2 σρ σ2
σρ3 σρ2 σρ σ2

 .
The three way interaction of side-by-group-by-timepoint is not significant (F = 0.50, df = 1, 168, p = 0.4823),
and neither are the two way side-by-group (F = 0.76, df = 1, 168, p = 0.3860), and side-by-timepoint
interactions (F = 2.25, df = 1, 168, p = 0.1359). On the other hand, the group-by-timepoint interaction
is significant (F = 8.47, df = 1, 168, p = 0.0041). The main effects of side, group, and timepoint are all
significant (F = 6.12, df = 1, 168, p = 0.0143; F = 4.05, df = 1, 168, p = 0.0457; and F = 19.52, df =
1, 168, p < 0.0001, respectively), but due to interaction, the main effect for diagnosis (i.e., group) is close to
clinically meaningless; i.e., the groups should be compared at each time point instead of an overall comparison
of group means. But, the main effects of timepoint and side being significant is interpretable between baseline
and follow-up.
Below we perform various post-hoc tests to see which groups are significantly different or significantly
change over time. To accomplish this, we test for differences at each timepoint, between baseline and follow-
up, and between left and right distances.
3.4 Post-Hoc Comparison of LDDMM Distances of CDR0.5 vs CDR0 Hip-
pocampi
For the p-values regarding the comparison of independent groups, see Table 7. The significant values at α =
0.05 are marked with *. None of the distance groups deviate significantly from normality (all p-values greater
than 0.10). That is, distance distribution of each group can be assumed to come from a Gaussian distribution.
Moreover, LB-CDR0.5 and LB-CDR0 distances can be assumed to have equal variances (p = 0.2948), and so
can RB-CDR0.5 and RB-CDR0 (p = 0.2273). But, the variance of LF-CDR0 distances is significantly smaller
than that of LF-CDR0.5 distances (p = 0.0294), and similarly for RF-CDR0 versus RF-CDR0.5 (p = 0.0262).
Therefore, for comparisons at baseline, we can use the p-values from the t-tests [68], while for follow-up
comparisons, it is more appropriate to use the p-values from Wilcoxon rank sum tests [67].
Observe that RF-CDR0.5 mean distances are significantly larger than RF-CDR0 mean distances at .05
level (p = 0.0106), and LF-CDR0.5 distances are significantly larger than LF-CDR0 distances at 0.10 level
(p = 0.0813). On the other hand, LB-CDR0.5 and LB-CDR0 distances are not significantly different (p =
0.5362), and likewise for RB-CDR0.5 and RB-CDR0 distances (p = 0.8176). This implies that at baseline,
the morphometric differences of CDR0.5 and CDR0 hippocampi with respect to the template hippocampus
are about same, which might indicate no significant shape differences in the left and right hippocampi due
to dementia. However, since the metric distances do not necessarily provide direction in either shape or
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size, this is not a decisive implication. At follow-up, left and right hippocampi of CDR0.5 subjects tend
to significantly differ in morphometry from the template compared to those of CDR0 subjects. Moreover,
this significance emanates over time; that is, right hippocampi of CDR0.5 subjects tend to undergo more
alteration in morphometry compared to those of CDR0 subjects over time.
3.5 Comparison of Baseline and Follow-up Metric Distances
For the comparison of dependent groups by paired difference method, see Table 7. The paired differences
in Table 7 can all be assumed to be normal based on Lilliefor’s test of normality. Hence, we use the more
powerful t−test for paired differences [68].
Observe that LB-CDR0.5 metric distances are significantly smaller than LF-CDR0.5 distances at α = .05
(p = 0.0259). Likewise for RB-CDR0 vs RF-CDR0.5 distances (p = 0.0002). That is, CDR0.5 hippocampi
tend to become more different in morphometry from the template, which implies that for both left and
right distances there is significant change in morphometry (perhaps reduction in size) of CDR0.5 hippocampi
over time. In fact, significant volume reduction over time is detected [29]. The morphometric changes in
CDR0.5 right hippocampi from baseline to follow-up is barely significantly larger than those of CDR0.5
left hippocampi (p = 0.0445). The associated p-value here is obtained by testing the difference sets (LB-
CDR0.5)-(LF-CDR0.5) versus (RB-CDR0)-(RF-CDR0.5) using the usual paired t-test. On the other hand,
only RB-CDR0 is almost significantly less than RF-CDR0 at .05 level (p = 0.0621), which implies there is
not strong evidence for shape change in control subjects over time, but some weak evidence for mild change
in right hippocampi can be detected as a result of aging. Furthermore, the morphometric changes in CDR0
right hippocampi from baseline to follow-up are not significantly different from those of CDR0 left hippocampi
(p = 0.3817).
The morphometric changes in CDR0.5 left hippocampi from baseline to follow-up are not significantly
different from those of CDR0 left hippocampi (p = 0.1337), while the morphometric changes in CDR0.5
right hippocampi from baseline to follow-up are significantly larger from those of CDR0 right hippocampi
(p = 0.0074). Therefore, over time, DAT influences the morphometry of right hippocampi more compared to
left hippocampi.
3.6 Comparison of LDDMM Distances of Left and Right Hippocampi
As for left vs right comparisons, LB-CDR0.5 and RB-CDR0.5 distances are not significantly different from
each other (p = 0.3046), LF-CDR0.5 distances are significantly smaller than RF-CDR0.5 distances at .05
level (p = 0.0179), the same holds for LB-CDR0 vs RB-CDR0.5 (p = 0.0215) and LF-CDR0 vs RF-CDR0
(p = 0.0021) comparisons. This implies that at baseline morphometric differences of CDR0.5 left hippocampi
from the left template are about the same as those of CDR0.5 right hippocampi from the right template.
On the other hand at follow-up, morphometric differences of CDR0.5 left hippocampi are smaller than those
of CDR0.5 right hippocampi. At baseline and follow-up, morphometric differences of CDR0 left hippocampi
from the left template are smaller than those of CDR0 right hippocampi. That is, CDR0 left hippocampi are
more similar in morphometry to the left template when compared to CDR0 right hippocampi to the right
template. These distance comparisons for left versus right hippocampi would imply left-right morphometric
asymmetry, only if the left and right hippocampi of the template subject were very similar (up to a reflection).
Otherwise, these comparisons are only suggestive of morphometric differences from the respective hemisphere
(side) of the hippocampi.
3.7 Analysis of the Correlation between Metric Distances of Dependent Hip-
pocampi
Correlation coefficients between metric distances for baseline and follow-up (overall and by group) and for the
left and right hippocampi are provided in Table 8 and Table 9, respectively, where Pearson’s product-moment
correlation coefficient is denoted as rP , Spearman’s rank correlation coefficient is denoted as ρS , and Kendall’s
rank correlation coefficient is denoted as τK [67, 68]. The corresponding null and alternative hypotheses are
11
Ho : correlation = 0 vs Ha : correlation > 0.
The values in the parentheses right of the correlation coefficients are the corresponding p-values. The
significant p-values at level α = 0.05 are marked with an asterisk (*). Since all groups can be assumed to be
normal, the more powerful Pearson’s correlation test will be used for inference.
Notice that from the correlation analysis of baseline vs follow-up, we see that the overall distances, L-
CDR0, and R-CDR0 are significantly correlated at 0.05 level. But LB-CDR0 and LF-CDR0 are significantly
correlated at .05 level based on Pearson’s test, and Spearman’s test, and at 0.10 by Kendall’s tests. However,
RB-CDR0 and RF-CDR0 are significantly correlated at 0.10 level by only Pearson’s test. This implies that
except for the CDR0 right hippocampi, the distances tend to increase at baseline together with distances at
follow-up. That is, as the morphometric differences from the template hippocampus increase at baseline, so
do the differences from the template at follow-up (except for CDR0 right hippocampi).
Notice also that from the correlation analysis of left and right distances, we observe that overall left and
right at baseline (LDB and RDB) distances are significantly correlated at .05 level, but LDF and RDF are
correlated at .05 level by Pearson’s test only, and 0.10 by Spearman’s test. And LB-CDR0 and RB-CDR0 have
significant correlation structure at .05 level. However, the correlation coefficients are not that large, which
suggests mild correlation between left and right metric distances. That is, as the morphometric differences of
left hippocampi from the left template increase, differences of right hippocampi from the right template tend
to increase slightly.
3.8 Comparison of Distributions of the Metric Distances
The samples (groups) should be independent for these tests to be valid, so we only compare LB-CDR0.5
vs LB-CDR0, RB-CDR0.5 vs RB-CDR0, LF-CDR0.5 vs LF-CDR0, and RF-CDR0.5 vs RF-CDR0. The
corresponding p-values for the two-sided and one-sided cdf comparison tests are provided in the Table 10,
where pKS is the p-value for the two-sided K-S test, with (l) and (g) are abbreviations of first cdf less than
the second and first cdf greater than the second, respectively, pC is the p-value for Crame´r’s test, and pCvM
is the p-value for Crame´r-von Mises test [65, 72].
Notice that at α = 0.05 level, the cdf of RF-CDR0.5 distances is significantly smaller than the cdf of
RF-CDR0 distances (p = 0.0259 for K-S test). That is, RF-CDR0.5 metric distances are stochastically larger
than RF-CDR0 right metric distances. In other words, RF-CDR0.5 hippocampus shapes are more likely to
be different than the template hippocampus compared to RF-CDR0 hippocampus shapes. Furthermore, the
cdf of LF-CDR0.5 distances is significantly smaller than the cdf of LF-CDR0 distances (p = 0.0604 by K-S
test and p = 0.0495 by Crame´r’s test); that is, LF-CDR0.5 metric distances are stochastically larger than
LF-CDR0 metric distances. See Figure 7 for the corresponding cdf plots. Observe that these results are in
agreement with the ones in Table 7.
3.9 Logistic Discrimination with Metric Distances
We model the probability that the subject has CDR0.5 given the hippocampal LDDMM distances of the
subject for left and right hippocampi at baseline and follow-up. First we consider the full logistic model
(designated as MI(D)) with the response logit p = log [p/(1− p)] where p = P (Y = 1) (i.e., the probability
that condition of the subject is CDR0.5); side, timepoint, and distance with all possible interactions are
the predictor variables. When the stepwise model selection procedure is applied, the resulting model is
logit pk = β0 + β1dijk where pk is the probability of subject k having DAT and dijk the distance for subject
k with diagnosis i (i = 1 for CDR0 and 2 for CDR0.5) at timepoint j (j = 1 for baseline and 2 for follow-up),
β0 is the intercept and β1 is the slope of the fitted line. However, the graph of the proportions of CDR0.5
subjects for grouped metric distances in Figure 8 suggests that the relationship is a quadratic one (in fact,
we found that the higher order distance terms are not significant). That is, the analysis of deviance table
indicates that only the linear and quadratic terms are significant (p = 0.001 and p = 0.010). So the resulting
model is
MII(D): logit pk = β0 + β1dijk + β2d
2
ijk (9)
where β2 is the coefficient of the quadratic term.
12
Using this logistic classifier with po = 0.5, we obtain classification summary matrix A in Table 11 for the
176 hippocampi MRI images in this data set. The labels on the left margin show the groups to which the
hippocampi MRIs are classified into, while the top margin shows the groups from which these MRI images
come. Observe that 95 out of 104 (91%) of the hippocampus MRIs from CDR0 subjects would be classified
correctly and 20 out of 72 (28%) of the hippocampus MRIs from CDR0.5 subjects are classified correctly.
However, in this logistic discrimination procedure, we treat each hippocampus from left, right, baseline or
follow-up hippocampi as a distinct subject. From a clinical point of view, each subject has four hippocampus
MRIs in this study, and one MRI classified as CDR0.5 would suffice to classify the subject as CDR0.5, while
all four MRIs should be classified as CDR0 for the subject to be classified as CDR0. With this classification
rule, we obtain the classification matrix B in Table 11. Notice that 18 out of 26 (69.2%) of the CDR0 subjects
would be classified correctly and that 10 out of 18 (55.6%) of the CDR0.5 subjects are classified correctly.
However, as we have seen in Section 3.1.3, due to group-by-timepoint interaction, we need to consider
diagnosis groups at each time point. When we use dBik and d
F
ik one at a time in a logistic model, we see that
only the model
MIII(D): logit pk = β0 + β1d
F
ik + β2
(
dFik
)2
(10)
has significant coefficients for the distance terms. Using this logistic model in the logistic classifier, we get the
classification matrix C in Table 11. Notice that 22 out of 26 (85%) of the CDR0 subjects would be classified
correctly and that 10 out of 18 (56%) of the CDR0.5 subjects are classified correctly.
Moreover, when we use dLBk , d
LF
k , d
RB
k , and d
RF
k one at a time in a logistic model, we see that only the
model
MIV (D): logit pk = β0 + β1d
RF
k (11)
has a significant coefficient for the distance term. Using dRFk and this logistic model in the logistic classifier,
we get the classification matrix D in Table 11. Notice that 22 out of 26 (85%) of the CDR0 subjects would
be classified correctly and that 8 out of 18 (44%) of the CDR0.5 subjects are classified correctly. The above
classification matrices are almost the same with leave-one-out cross-validation with logistic discrimination
(not presented).
We also calculate the sensitivity and specificity of the classification procedures summarized in Table 12.
Sensitivity is the proportion of subjects that are classified to be CDR0.5 (i.e., positive) of all CDR0.5 subjects.
That is, sensitivity is defined as Psens =
TCDR0.5
NCDR0.5
×100% where TCDR0.5 is the number of correctly classified
CDR0.5 subjects and NCDR0.5 is the total number of CDR0.5 subjects in the data set (i.e., NCDR0.5 = 18
in our data). Notice that the higher the sensitivity, the fewer real cases of DAT go undetected. Specificity is
the proportion of subjects that are classified CDR0 (i.e., negative, control, or healthy) of all CDR0 subjects;
that is Pspec =
TCDR0
NCDR0
×100% where TCDR0 is the number of correctly classified CDR0 subjects and NCDR0
is the total number of CDR0 subjects in the data set (i.e., NCDR0 = 26 in our data). Notice that the
higher the specificity, the fewer healthy people are labeled as sick. The correct classification rates, sensitivity
and specificity percentages for the classification matrices A-D are presented in Table 12. Observe that best
classification performance is with the logistic model MIII(D) in Equation (10) with one CDR0.5-labeled
hippocampus enough to label the subject to have CDR0.5 (see matrix C in Table 11). Furthermore, in these
classification procedures, specificity rates are (significantly) larger than the sensitivity rates.
We could also change the threshold probability po in Equation (5). The correct classification rates,
sensitivity, and specificity percentages with models MI(D)−MIV (D) and po ∈ {1/2, 18/44} are presented in
Table 13. Observe that with po = 1/2 the best classifier is based on MIII(D) and with po = 18/44 the best
classifier is based on MIV (D). Setting po = 18/44 (the proportion of CDR0.5 subjects in the data set) we
get higher sensitivity rates than those with po = 1/2. However, as po decreases, the correct classification rate
and specificity tend to decrease.
One can optimize the threshold value of po in Equation (5) to maximize the correct classification rates
and minimize the misclassification rates using an appropriately chosen cost function. For example one can
consider the cost function
C1(po, w1, w2) = − (TCDR0 − FCDR0)
w1 (TCDR0.5 − FCDR0.5)
w2 , (12)
where w1 ≤ w2 are positive odd numbers, FCDR0 is the number of CDR0.5 subjects classified (falsely) as
CDR0 and FCDR0.5 is the number of CDR0 subjects classified (falsely) as CDR0.5. Notice that minimizing
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this cost function will maximize the correct classification rates and minimize the misclassification rates. The
correct classification rates, sensitivity and specificity rates are provided in Table 13. Using w1 = w2 = 1,
optimal threshold values are po = 0.5 for model MII(D) in Equation (9), po = 0.45 for model MIII(D) in
Equation (10), and optimal po = 0.38 for model MIV (D) in Equation (11). The specificity rates are 69%,
73%, and 69%, respectively. The sensitivity rates are 56%, 67%, and 72%, respectively. Obviously, from a
clinical point of view, misclassifying a CDR0.5 subject as CDR0 (i.e., classifying a diseased subject as healthy)
might be less desirable, since a subject labeled as CDR0.5 will undergo further screening but a subject labeled
as CDR0 will be released. So the parameters w1 and w2 could be modified to reflect such practical concerns
and then a different set of threshold po values could be found. For example, we set w1 = 1 and w2 = 3
which favors correct classification of CDR0.5 subjects more than that of CDR0 subjects (i.e., favors higher
sensitivity). Observe that with w1 = w2 = 1 the best classifier is based on model MIV (D) and with w1 = 1
and w2 = 3 the best classifier is based on model MIII(D).
Alternatively we can maximize the sensitivity and specificity rates by minimizing the following cost func-
tion
C2(po, η1, η2) = −
[
η1
(TCDR0 − FCDR0)
NCDR0
+ η2
(TCDR0.5 − FCDR0.5)
NCDR0.5
]
, (13)
where η1, η2 ≥ 0 and η1 + η2 = 1. Notice that as either of sensitivity or specificity increases, the cost
function C2(po, η1, η2) decreases. With η1 = η2 = 0.5 the best classifier is based on model MIV (D) and
with η1 = .3, η2 = 0.7 the best classifier is based on model MIII(D). Observe that from η1 = η2 = 0.5 to
η1 = .3, η2 = 0.7, sensitivity increases, correct classification rate and specificity tend to decrease.
4 Analysis of Hippocampal Volumes
The LDDMM distance gives one number reflecting the global size and shape. Volume measurements were
presented in detail in [29]. The LB-CDR0 subjects had an average hippocampal volume of 2081 ( ± 354) mm3
while RB-CDR0 subjects had 2600 ( ± 481) mm3. The LB-CDR0.5 subjects had an average hippocampal
volume of 1717 ( ± 224) mm3 and RB-CDR0.5 had 2186 ( ± 370) mm3. On the other hand, LF-CDR0
subjects showed a volume reduction of 82 mm3 (4.0%, NS) and RF-CDR0 subjects showed a reduction
of142 mm3 (5.5%, NS) where NS stands for “not significant”. LF-CDR0.5 subjects had hippocampal volume
reduction of 164 mm3 (8.3%, p = 0.03) and RF-CDR0.5 subjects had reduction of 236 mm3 (10.2%, p = 0.05)
on the right side. Repeated-measures ANOVA showed both significant change over time (within group,
F = 98.97, df = 1, 42, p < .0001) and significant time-group interaction (F = 7.81, df = 1, 42, p = 0.0078)
in the hippocampal volumes. The time-group interaction persisted when covaried with baseline total cerebral
brain volume (p = 0.0066) or with baseline total intracranial volume (p = 0.0077). In order to take into
account variations in between-visit intervals (mean 2.11 ± 0.47 years), scan interval was also used as a
covariate in the volumes comparison. Again, the significant time ×group interaction after covarying for scan
intervals (p = 0.015) persisted.
4.1 Repeated Measures Analysis of Hippocampal Volumes
We repeat the same modeling procedure of Section 3.1 on the hippocampal volumes. For modeling hip-
pocampal volumes using the repeated measures ANOVA with group as main effect and compound symmetry
in Var-Cov structure and volume measurements repeated over time for each subject, the model is
Vijk = µ+ α
D
i + α
T
j + α
DT
ij + εijk, (14)
where Vijk is the volume for subject k with diagnosis i at timepoint j, µ is the overall mean, α
D
i is the effect of
diagnosis level i, αTj is the effect of timepoint level j, α
DT
ij is the diagnosis-by-timepoint interaction, i.e., part of
the mean volume not attributable to the additive effect of diagnosis and timepoint, and εijk is the error term.
Notice that the effect of side (left or right) is ignored in this model. There is significant group main effect (F =
17.54, df = 1, 42, p = 0.0001) and within group time-point main effect (F = 9.87, df = 1, 130, p = 0.0021)
but the group-by-timepoint interaction is not significant (F = 0.84, df = 1, 130, p = 0.3624). This implies
that the main effect of group comparison is meaningful and about the same at each timepoint. Moreover, the
groups do change in morphometry over time.
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For modeling volumes using the repeated measures ANOVA with side as main effect and compound
symmetry in Var-Cov structure and volume measurements repeated over time, the corresponding model is
Vijk = µ+ α
S
i + α
T
j + α
ST
ij + εijk, (15)
where Vijk is the volume for subject k for side i (i = 1 for left; 2 for right) at timepoint j, µ is the overall
mean, αSi is the effect of side level i, α
T
j is the effect of timepoint level j = 1, 2, α
ST
ij is the side-by-timepoint
interaction, and εijk is the error term. Notice that the effect of diagnosis (CDR0 or CDR0.5) is ignored in
this model. The side and timepoint main effects are both significant (F = 377.21, df = 1, 129, p < .0001
and F = 38.31, df = 1, 129, p < .0001, respectively), but side-by-timepoint interaction is not significant
(F = 1.84, df = 1, 129, p = 0.1769). Consequently, we conclude that the lines that join mean volumes in the
interaction plot are parallel and far apart, the main effect of side comparison is meaningful, and about the
same at each timepoint. Moreover, the left and right hippocampi do change in morphometry over time.
For the model that includes the diagnosis, side, and diagnosis-by-side interaction, we use the same model
selection criteria in Section 3.1.3. We find that the most promising model based on likelihood ratio test, BIC,
and AIC is the one with unstructured Var-Cov matrix. The corresponding model with significant terms at
α = .05 level is
Vijkl = µ+ α
S
i + α
D
j + α
T
k + α
ST
ik + α
DT
jk + εijkl, (16)
where Vijkl is the volume for subject l for side i with diagnosis j at timepoint k, µ is the overall mean, α
S
i is
the effect of side level i, αDj is the effect of diagnosis level j, α
T
k is the effect of timepoint level k = 1,3, α
ST
ik is
the side-by-timepoint interaction, αDTjk is the diagnosis-by-timepoint interaction, and εijkl is the error term.
The (unstructured) Var-Cov structure for the error term is
Cov(εijkl, εi′jk′l) =


σ2
σ21 σ
2
σ31 σ32 σ
2
σ41 σ42 σ43 σ
2

 .
The main effects of side, group, and timepoint are all significant (F = 120.10, df = 1, 170, p < .0001;
F = 25.25, df = 1, 170, p < .0001; and F = 89.53, df = 1, 170, p < 0.0001, respectively). But due to
interaction, the main effect for diagnosis (i.e., group) is close to clinically meaningless, i.e., the group means
should be compared at each time point or hemisphere instead of comparing the overall means of the groups.
But, the main effects of group and side being significant are interpretable between baseline and follow-up.
4.2 Post-Hoc Comparison of Hippocampal Volumes for Differences in Group,
Time, and Hemisphere
We repeat the analysis procedure of Section 3 on hippocampal volumes also. We find that left hippocampus
volumes are significantly smaller than the right hippocampus volumes at both baseline and follow-up years
(i.e., there is significant volumetric left-right asymmetry in hippocampi); baseline volumes are larger than
follow-up volumes for both left and right hippocampi (i.e., there is significant reduction in volume by time)
(p < .0001 for each comparison). The means and standard deviations of the volumes for left and right
hippocampi of each group are provided in Table 1. We observe the same trend in the overall comparison for
each group also. However, left-right volumetric asymmetry significantly reduces by time in CDR0.5 group
(p = .0407); but the same holds only barely in CDR0 group (p = .0524). The level of left-right volumetric
asymmetry is about the same in both CDR0 and CDR0.5 groups at baseline (p = .3495) and follow-up
(p = .4853). The volumes decrease significantly by time in CDR0 group for both left and right hippocampi
(p < .0001 for both); the same holds for CDR0.5 group also (p = .0001 for both). The volumetric reduction
is significantly larger in CDR0.5 right hippocampi compared to CDR0.5 left hippocampi (p = .0407); but
the same holds only barely in CDR0 group (p = .0524). On the other hand, the volumetric reduction is
significantly larger in CDR0.5 left hippocampi compared to CDR0 left hippocampi (p = .0108); the same
holds for right hippocampi also (p = .0418). The variances of volumes are not significantly different for
(LB-CDR0.5, LB-CDR0), (RB-CDR0.5, RB-CDR0), and (RF-CDR0.5, RF-CDR0) groups, but volumes of
LF-CDR0 hippocampi are significantly larger than LF-CDR0.5 hippocampi (p = .0268). The CDR0.5 volumes
are significantly smaller than CDR0 volumes in left hippocampi at baseline (p = .0001) and follow-up (p <
.0001), and for right hippocampi at baseline (p = .0071) and follow-up (p = .0001). The CDR0.5 volumes
15
are stochastically smaller than CDR0 volumes for left hippocampi at baseline (p = .0007) and follow-up
(p = .0003), and for right hippocampi at baseline (p = .0064) and follow-up (p = .0028).
4.3 Logistic Discrimination with Hippocampal Volumes
We apply the logistic discrimination methods of Section 3.7 on hippocampal volumes. First we consider the
full logistic model (designated as MI(V )) with side, timepoint, and volume with all possible interactions
being the predictor variables. We apply the same stepwise elimination procedure as in Section 3.7 and get
the following reduced model:
MII(V ): logit pl = β0 + α
S
k + β1Vijkl , (17)
where pl is the probability of subject l having DAT and Vijkl the volume for subject l with diagnosis i ( i = 1
for CDR0 and 2 for CDR0.5) at timepoint j (j = 1 for baseline and 2 for follow-up) with side k (k = 1 for
left and 2 for right), β0 is the overall intercept, α
S
k is the effect of side level k, and β1 is the slope of the fitted
line.
However, as we have seen in Section 3.1.3, due to group-by-timepoint interaction, we need to consider
diagnosis groups at each time point. When we use V Bikl and V
F
ikl one at a time in a logistic model, we see that
the model
MIII(V ): logit pl = β0 + α
S
k + β1V
F
ikl (18)
has the most significant coefficients for the volume terms.
Moreover, when we use V LBkl , V
LF
kl , V
RB
kl , and V
RF
kl one at a time in a logistic model, we see that the
following model has the best fit.
MIV (V ): logit pl = β0 + β1V
LF
kl (19)
The classification rates are presented in Table 15. Observe that with po = 1/2 the best classifier is based
on model MIII(V ) and with po = 18/44 the best classifier is based on model MIV (V ). Furthermore, as po
decreases from 1/2, sensitivity increases but the correct classification rate and specificity decreases. We use
the cost function C1(po, w1, w2) with w1 = w2 = 1 and with w1 = 1 and w2 = 3 to calculate the optimal po
values for each of the models MI(V ) −MIV (V ). Observe that with w1 = w2 = 1 the best classifier is based
on model MIV (V ) and with w1 = 1 and w2 = 3 the best classifier is based on model MIII(V ). We find the
optimal po values based on the cost function C2(po, η1, η2) with η1 = η2 = 0.5 and with η1 = .3, η2 = 0.7
for each of models MI(V )−MIV (V ). With η1 = η2 = 0.5 the best classifier is based on model MIV (V ) and
with η1 = .3, η2 = 0.7 the best classifier is based on model MI(V ). Observe that from η1 = η2 = 0.5 to
η1 = .3, η2 = 0.7, sensitivity increases, correct classification rate and specificity tend to decrease.
5 Comparison of Hippocampal Volumes and Metric Distances
Although volume is a measure of size and metric distance is a measure of overall morphometric difference
from a template, the repeated measure analysis and post-hoc analysis of volumes and metric distances provide
similar results. The main difference is that volumes tend to decrease, while LDDMM distances tend to increase
by time.
The logistic discrimination models are similar, except model MIV (D) for metric distances contains right
follow-up distances, while model MIV (V ) for volumes contains left follow-up volumes. The classification
performances with po = 1/2 and po = 18/44 suggest that volume models have better performance than
the metric distance models (see Tables 13 and 15). Using the optimal po values with the cost functions
C1(po, w1, w2) and C2(po, η1, η2), the classification performances are significantly different for modelsMI(V )−
MIV (V ) of volumes andMI(D)−MIV (D) metric distances. Comparing Tables 13 and 15, we see that logistic
discrimination with volumes has better performance.
We apply the logistic discrimination using both volume and metric distance as predictors. The models we
consider are the full logistic model (designated as model MI(V,D)) with side, timepoint, volume, and metric
distances with all possible interactions being predictor variables. We apply the same stepwise elimination
procedure as in Section 3.7 and get
MII(V,D): logit pl = β0 + α
S
k + β1Vijkl + β2d
9
ijkl + β3Vijkldijkl
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where pl is the probability of subject l having DAT and Vijkl the volume and dijkl the distance for subject l
with diagnosis i (i = 1 for CDR0 and 2 for CDR0.5) at timepoint j (j = 1 for baseline and 2 for follow-up)
with side k (k = 1 for left and 2 for right), β0 is the overall intercept, α
S
k is the effect of side level k, β1 is
the coefficient for volume, β2 is the coefficient for ninth power of the distance, β3 is the coefficient for the
interaction between volume and distance. When we use baseline or follow-up measures one at a time in a
logistic model, we see that the model
MIII(V,D): logit pl = β0 + α
S
k + β1V
F
ikl + β2
(
dFikl
)5
has the most significant coefficients. When we use side-by-timepoint combinations one at a time in a logistic
model, we see that the following model has the best fit:
MIV (V,D): logit pl = β0 + β1
(
dFikl
)3
+ β2V
LF
kl .
The corresponding classification rates are presented in Table 16. Observe that considering metric distance
and volume together in the logistic discrimination procedure with the cost functions C1(po, w1, w2) and
C2(po, η1, η2), we get better classification rates compared to logistic models with only one of metric distance
or volume being the predictors.
6 Annual Percentage Rates of Change in Hippocampal Volumes
and Metric Distances
Our volume and LDDMM metric comparisons are cross-sectional or longitudinal by construction. However
these measures might need to be adjusted for anatomic variability, since intersubject variability might add
substantial amount of noise to volume or distance measurements at baseline or follow-up. There is no simple
way to correct for this noise in practice. Differential volume loss or distance change over time might be
self-correcting for such variability. For example, entorhinal cortex volume loss over time was shown to be a
better indicator for DAT than cross-sectional measurements [73].
6.1 Annual Percentage Rate of Change in Hippocampal Volume
The hippocampal volume change over time can be written as the following annual percentage rate of change
(APC) [73]:
V APC =
V bk − V
f
k
V bk × T
× 100%, (20)
where T is the interscan interval in years (T ≈ 2 in our data).
For modeling annual percentage rate of change in volume V APC using the repeated measures ANOVA
with group as main effect and compound symmetry in Var-Cov structure and V APC measures repeated over
side for each subject, the model is
V APCijk = µ+ α
D
i + α
S
j + α
DS
ij + εijk, (21)
where V APCijk is the APC in volume for side j of subject k with diagnosis i, µ is the overall mean, α
D
i is the
effect of diagnosis level i (i = 1 for CDR0; 2 for CDR0.5), αSj is the effect of side level j (j = 1 for left and
2 for right), αDSij is the diagnosis-by-side interaction, and εijk is the error term. The diagnosis main effect is
significant (F = 18.62, df = 1, 84, p < .0001) but neither side main effect (F = 0.72, df = 1, 84, p = .3754)
nor diagnosis-by-side interaction is significant (F = 0.11, df = 1, 84, p = 0.7384). Consequently, we conclude
that the lines that join the mean V APC values in the interaction plot are parallel and far apart, the main effect
of diagnosis comparison is meaningful, and about the same at each hemisphere. The post hoc comparison of
V APC values indicate that the APC in CDR0.5 volumes are significantly larger than APC in CDR0 volumes
(p = .0001) .
We apply the logistic discrimination methods of Section 3.7 on APC in hippocampal volumes. First we
consider the full logistic model (designated as MI
(
V APC
)
) with side and APC in volume with all possible
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interactions being the predictor variables. We apply the same stepwise elimination procedure as in Section
3.7 and get
MII
(
V APC
)
: logit pk = β0 + β1V
APC
ijk + β2
(
V APCijk
)3
(22)
where pk is the probability of subject k having DAT.
Furthermore, when we use V APC,Lijk and V
APC,R
ijk as predictors in a logistic model, we see that the following
model has the best fit.
MIII
(
V APC
)
: logit pk = β0 + β1V
APC,L
ik + β2V
APC,R
ik + β3
(
V APC,Lik
)2
. (23)
The classification rates with po = 1/2 and po = 18/44 and optimal po values with respect to the cost
functions are presented in Table 17. Observe that the classifier using the cost function C2(po, η1, η2) with
η1 = .3, η2 = 0.7 in model MI
(
V APC
)
has the best performance. Comparing Tables 15 and 16, we observe
that correct classification rates, sensitivity, and specificity percentages with the classifiers based on APC in
volume are about the same as those with volume only. Unlike the findings of [73] hippocampal volume loss
over time is not a better indicator for DAT than cross-sectional measurements. On the other hand, the
classifier based on volume and distance together performs better compared to models based on only one of
volume, distance, or APC in volume values.
6.2 Annual Percentage Rate of Change in LDDMM Metric Distance
The hippocampal LDDMMmetric distance change over time can be written as the following annual percentage
rate of change:
DAPC =
dfk − d
b
k
dbk × T
× 100%. (24)
Notice that to make APC in metric distance positive, we take the difference dfk − d
b
k as opposed to the order
in the APC in volume definition For modeling DAPC using the repeated measures ANOVA with group as
main effect and compound symmetry in the Var-Cov structure and DAPC measures repeated over side for
each subject, the model is
DAPCijk = µ+ α
D
i + α
S
j + α
DS
ij + εijk, (25)
where DAPCijk is the APC in LDDMM metric distance for side j of subject k with diagnosis i. The other
terms are as in Equation (21). The diagnosis main effect is significant (F = 4.75, df = 1, 84, p = .0320)
but neither side main effect (F = 2.29, df = 1, 84, p = .1338) nor diagnosis-by-side interaction is significant
(F = 0.87, df = 1, 84, p = 0.3532). Consequently, we conclude that the lines that join the means in the
interaction plot are parallel and far apart, the main effect of diagnosis comparison is meaningful, and about
the same at each hemisphere. The APC in CDR0.5 LDDMM distances is significantly larger (in absolute
value) than APC in CDR0 distances (p = .0036) .
We apply the logistic discrimination methods of Section 3.7 on APC in hippocampal LDDMM distances.
First we consider the full logistic model (designated as MI
(
DAPC
)
) with side and APC in distance with all
possible interactions being the predictor variables. We apply the same stepwise elimination procedure as in
Section 3.7 and get
MII
(
DAPC
)
: logit pk = β0 + β1D
APC
ijk . (26)
Furthermore, when we use DAPC,Lijk and D
APC,R
ijk as predictors in a logistic model, we see that the following
model has the best fit.
MIII
(
DAPC
)
: logit pk = β0 + β1D
APC,R
ik . (27)
The classification rates with po = 1/2 and po = 18/44 and optimal po values with respect to the cost func-
tions are presented in Table 18. Observe that these classifiers have relatively poor performance. Comparing
each of Tables 13 and 18, we observe that the classifiers with the optimal po values have much larger sensitivity
rates but this increase comes at the expense of substantial decrease in correct classification rate and specificity.
Hence hippocampal LDDMM change over time is not a better indicator for DAT than cross-sectional distance
comparisons.
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6.3 Annual Percentage Rate of Change in Hippocampal Volume and Metric
Distances
We apply the logistic discrimination based on distance and APC in volumes. First we consider the full
logistic model (designated as MI
(
V APC , D
)
) with side and APC in volume, and distances with all possible
interactions being the predictor variables. We apply the same stepwise elimination procedure as in Section
3.7 and get
MII
(
V APC , D
)
: logit pk = β0 + β1V
APC
ijk + β2
(
V APCijk
)3
+ β3
(
dFik
)2
. (28)
Furthermore, when we use and left and right measures as predictors in a logistic model, we see that the
following model has the best fit.
MIII
(
V APC , D
)
: logit pk = β0 + β1V
APC,L
ik + β2V
APC,R
ik + β3d
RF
ik . (29)
The classification rates with po = 1/2 and po = 18/44 and optimal po values with respect to the cost
functions are presented in Table 19. With the cost function C1(po, w1 = 1, w2 = 1), the best classifier is
based on MIII
(
V APC , D
)
for which the optimal threshold value is po ≈ .37, the correct classification rate
is 80%, sensitivity is 78%, and specificity is 81%. Likewise, with the cost function C1(po, w1 = 1, w2 = 3),
the best classifier is based on MI
(
V APC , D
)
for which the optimal threshold value is po = .56, the correct
classification rate is 80%, sensitivity is 78%, and specificity is 81%. On the other hand, with cost function
C2(po, η1 = .5, η2 = .5) the best classifier is based on M
APC
I (V,D) for which the optimal threshold value is
po = .64, the correct classification rate is 84%, sensitivity is 72%, and specificity is 92%. With cost function
C2(po, η1 = .3, η2 = .7), the best classifier is again based on M
APC
I (V,D) for which the optimal threshold
value is po = .56, the correct classification rate is 80%, sensitivity is 78%, and specificity is 81%. Comparing
Tables 16 and 19, we observe that the classifiers based on metric distance and volume usually perform better
compared to the classifiers based on metric distance and APC in volume. Comparing Table 17 and 19, we
observe that adding the metric distance to the logistic model with APC in volume improves the classification
performance. Hence the model with hippocampal volume loss over time and metric distance is a better
indicator for DAT compared to either variable used separately in logistic discrimination.
We also apply the logistic discrimination based on volume, distance, and APC in volumes. First we
consider the full logistic model (designated as MI
(
V, V APC , D
)
) with side, volume, and APC in volume, and
distances with all possible interactions being the predictor variables. We apply the same stepwise elimination
procedure as in Section 3.7 and get
MII
(
V, V APC , D
)
: logit pk = β0 + β1V
B
ijk + β2V
APC
ijk + β3
(
V APCijk
)3
+ β4
(
dFijk
)3
. (30)
Furthermore, when we use and left and right measures as predictors in a logistic model, we see that the
following model has the best fit.
MIII
(
V, V APC , D
)
: logit pk = β0 + β1V
RF
ik + β2d
LF
ik + β3V
APC,R
ik + β4
(
V APC,Lik
)3
+ β5
(
dRFik
)3
. (31)
The classification rates with po = 1/2 and po = 18/44 and optimal po values with respect to the cost
functions are presented in Table 20. With the cost function C1(po, w1 = 1, w2 = 1), the best classifier is
based on MIII
(
V, V APC , D
)
. Comparing Table 20 with Tables 13, 15, 17, 18, 16, and 19, we observe that
the classifiers based on metric distance, volume, and APC in volumes usually perform better compared to
the classifiers based on other models. Hence the model with volume, hippocampal volume loss over time, and
metric distance is a better indicator for DAT compared to other models based on subsets of these variables.
7 Discussion and Conclusions
In this study, we used the Large Deformation Diffeomorphic Metric Mapping (LDDMM) algorithm to generate
metric distances between hippocampi in groups of subjects with and without Dementia of Alzheimer’s type
(DAT) in its mild form (labeled as CDR0.5 and CDR0 patients, respectively) at baseline and at follow-up.
The subjects in this paper have been previously analyzed using related but different tools. As a single scalar
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measure, volumes were used for diagnosis group comparisons at baseline and follow-up [29] and displacement
momentum vector fields based on LDDMM were used for discrimination [57]. But the metric distances
computed from LDDMM has not hitherto been used in diagnosis group analysis. The metric distance gives a
single number reflecting the global morphometry (i.e., the size and shape) while volume measurements only
provide information on size. So metric distances provide morphometric information not conveyed by volume
whereas momentum vector fields also provide local information on shape changes. Further, the morphometric
information conveyed by the metric distance depends on the choice of the template, while the morphometric
information conveyed by momentum vector fields is independent of the template chosen. That is, although
the vector fields change when the template changes, the morphometric information they convey is the same.
Previously, it has been shown that hippocampal volume loss and shape deformities observed in subjects
with DAT distinguished them from both elderly and younger control subjects [10]. The pattern of hippocampal
deformities in subjects with DAT was largely symmetric and suggested damage to the CA1 hippocampal
subfield [74]. Hippocampal shape changes were also observed in healthy elderly subjects, which distinguished
them from healthy younger subjects. These shape changes occurred in a pattern distinct from the pattern
seen in DAT and were not associated with substantial volume loss [75].
Furthermore, Wang et al. [45] analyzed the baseline hippocampi of the same data set and showed that the
very mild DAT subjects showed significant inward variation in the left and right lateral zones (LZ) the left and
right intermediate zone (IMZ), but not in the left and right superior zones (SZ) as compared to CDR0 subjects.
In their logistic regression analysis, inward variation of the left and right LZ or IMZ by 0.1 mm relative to
the average of the nondemented subjects increased the odds of the subject being a very mild DAT subject
rather than being a nondemented subject. The odds ratios for the left and right SZ were not significant.
These results represented a replication of their previous findings [10] and suggest that inward deformities of
the hippocampal surface in proximity to the CA1 subfield and subiculum can be used to distinguish subjects
with very mild DAT from CDR0 subjects [45]. However, although momentum vector fields obtained by the
LDDMM algorithm can be used to detect such local (i.e., location specific) morphometric changes (as in the
CA1 subfield), metric distance does not provide such local information, hence fails to indicate any type of
laterality differences.
The main results in this paper are that although metric distances did not detect any significant difference
in morphometry at baseline (see Table 7), follow-up metric distances for the right hippocampus in CDR0.5
(i.e., mildly demented) subjects are found to be significantly larger than those in CDR0 (i.e., non-demented)
subjects (see Table 7). Wang et al. also analyzed the velocity vector fields for the baseline hippocampi of the
same data set and found that the left hippocampus in the DAT group shows significant shape abnormality
and the right hippocampus shows similar pattern of abnormality [57]. Again, the reason for the metric
failing to detect such abnormality in the baseline hippocampi is that metric distance is a compound and
oversummarizing measure of global morphometry. From baseline to follow-up, metric distances for CDR0.5
subjects significantly increase while those in CDR0 subjects do not (see Table 7). That is, the morphometry
(shape and size) of hippocampus in CDR0.5 subjects changes significantly over time, but not in CDR0
subjects. Atrophy – over two years – might occur with aging, and this is captured by metric distances (see
Table 7). However the increase in the metric distances in CDR0 subjects is not found to be statistically
significant.
Such differences in morphometry between diagnosis groups or morphometric changes over time can be
detected by metric distances computed via LDDMM and could potentially serve as a biomarker for the
disease. Previously, the volumes and velocity vector fields associated with the same data set (i.e., baseline
and follow-up of both groups) were also analyzed and it was found that hippocampal volume loss over time
was significantly greater in the CDR0.5 subjects (left = 8.3%, right = 10.2%) than in the CDR0 subjects
(left = 4.0%, right = 5.5%) (ANOVA, F = 7.81, p = 0.0078). Using singular-value decomposition and
logistic regression models, [45] quantified hippocampal shape change across time within individuals, and this
shape change in the CDR0.5 and CDR0 subjects was found to be significantly different (Wilks’ λ, p = 0.014).
Further, at baseline, CDR0.5 subjects, in comparison to CDR0 subjects, showed inward deformation over 38%
of the hippocampal surface; after 2 years this difference grew to 47%. Also, within the CDR0 subjects, shape
change between baseline and follow-up was largely confined to the head of the hippocampus and subiculum,
while in the CDR0.5 subjects, shape change involved the lateral body of the hippocampus as well as the head
region and subiculum. These results suggest that different patterns of hippocampal shape change in time as
well as different rates of hippocampal volume loss distinguish very mild DAT from healthy aging [29].
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In regard to statistical analysis, as a compound but brief measure of morphometry, metric distances
can thus serve as a first step to identify the morphometric differences, and can be used as a pointer to
which direction a clinician or data analyst could go. The importance of the CDR0 versus CDR0.5 contrast
analyzed here is that it tests a necessary but not sufficient condition for the eventual goal of discriminating
CDR0s who subsequently convert to CDR0.5, from CDR0s who subsequently stay CDR0. As subjects are
followed longitudinally and some convert, we have shown that cross-sectional measures of the hippocampal
structure can be used to predict those who convert. Metric distances may also be used in this way. When
baseline and followup of converted and nonconverted nondemented subjects were analyzed, it was found that
the inward variation of the lateral zone and left hippocampal volume significantly predicted conversion to
CDR0.5 in separate Cox proportional hazards models. When hippocampal surface variation and volume were
included in a single model, inward variation of the lateral zone of the left hippocampal surface was selected
as the only significant predictor of conversion. The pattern of hippocampal surface deformation observed
in nondemented subjects who later converted to CDR0.5 was similar to the pattern of hippocampal surface
deformation previously observed to discriminate subjects with very mild DAT and nondemented subjects.
These results suggest that inward deformation of the left hippocampal surface in a zone corresponding to the
CA1 subfield is an early predictor of the onset of DAT in nondemented elderly subjects [74]. This appears to
contradict our finding that the morphometric changes in CDR0.5 right hippocampi from baseline to follow-
up is significantly larger than those of CDR0.5 left hippocampi (p = 0.044). The morphometric changes in
CDR0 right hippocampi from baseline to follow-up are not significantly different from those of CDR0 left
hippocampi (p = 0.382). The morphometric changes in CDR0.5 left hippocampi from baseline to follow-up
are not significantly different from those in CDR0 left hippocampi (p = 0.134), while the morphometric
changes in CDR0.5 right hippocampi from baseline to follow-up are significantly larger than those of CDR0
right hippocampi (p = 0.007). Therefore, over time, DAT may alter the (global) morphometry of the right
hippocampus. However, note that the finding in [74] are concerned with changes in (local) subregions of
hippocampi, while metric distance is concerned with overall morphometric changes. That is, DAT might
implicate CA1 of the left hippocampi, yet the overall change in morphometry of right hippocampi might be
more substantial. Moreover, in [74] the converted (from CDR0 to CDR0.5) subjects were analyzed separately,
which we do not consider such conversion in our analysis. Also, metric distance results agree with the volume
comparisons of [29], hence volume (i.e., scale) might be highly dominating the morphometric changes in the
hippocampi. In other words, the significant volume reduction in left and right hippocampi might dominate
the change in shape, when morphometry is measured by metric distances. To remove the size influence so as
to measure the shapes only, one can perform scaling on the hippocampi and then apply LDDMM to normalize
the size differences.
Differences and changes (over time) in morphometry can also be used for diagnostic discrimination of sub-
jects in non-demented or demented groups. Many discrimination techniques such as Fisher’s linear discrimi-
nant functions, support vector machines, and logistic discrimination can be applied to the metric distances,
together with other qualitative variables. In this study we applied logistic discrimination based on metric dis-
tances, as logistic regression not only provides a means for classification, but also yields a probability estimate
for having DAT. Furthermore, one can optimize the threshold probability for a particular cost function for the
entire training data set, or by a cross-validation technique. The correct classification rate of the hippocampi
was about 70% in our logistic regression analysis. In [57] PCA of the initial momentum of the same data set
led to correct classification of 12 out of 18 (i.e., 67% of the) demented subjects and 22 out of 26 (i.e., 85%
of the) control subjects. Metric distances can be used to distinguish AD from normal aging quantitatively;
however, to be able to use it for diagnostic purposes, the method should be improved to a greater extent.
We perform a principal component analysis on metric distances and hippocampus, brain, and intracranial
volumes. Considering the variable loadings, we conclude that volumes are mostly measures of size and partly
related to shape, while the metric distance is mostly a measure of shape and partly related to size.
We also compare the cross-sectional, longitudinal, and discrimination results of LDDMM distances with
those of volumes. We observe that cross-sectional and longitudinal analysis give similar results, although
metric distances increase and volumes decrease by time. The metric distance, being an extremely condensed
summary measure give very similar results as the hippocampal volume. That is, neither volume nor metric dis-
tance discriminated left baseline (LB), right baseline (RB), or left followup (LF) between CDR0 and CDR0.5;
volume reduction and metric distances differences are both significant for CDR0.5 subjects, but neither of
them are significant for CDR0 subjects; and ANOVA suggested a significant diagnosis group-by-timepoint
interaction for both measures. On the other hand, we obtain better classification results with using volumes
21
compared to metric distances. When volume and LDDMM distances are used together, the classification
results improve compared to results based on volume or distance only. Furthermore, the differential volume
and distance changes are measured by annual percentage rate of change (APC) for the two year period in
the study. Similar to the results of [71], we found that APC in volumes may be a good indicator for early
stage of DAT. However, APC in LDDMM distances do not provide a good performance in classification of
CDR0 versus CCDR0.5 hippocampi. Comparing the discrimination results, we found that the classifier based
on volume, distance, and APC in volume has the best performance. Hence these measures may constitute a
reliable biomarker when used together.
In conclusion, we have presented detailed statistical analysis of metric distances computed with LDDMM
and show that this is potentially a powerful tool in detecting morphometric changes between diagnosis groups
or changes in morphometry over time. Furthermore, we avoid the single subject analysis, which might be
of greater interest clinically. Metric distances depend on the choice of template anatomy used. However, in
this article we do not address the issue of template selection for optimal differentiation between hippocampus
morphometry.
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I- Summary Information of Subjects
Gender (M/F) Age (years) Scan interval Education (years)
Gender (M/F) (mean ± SD) (years) ([Min-Max]) (mean ± SD)
CDR0 12/14 75.2±7.0 2.2 [1.4-4.1] 14.8± 2.7
CDR0.5 11/7 75.7±4.4 2.0 [1.0-2.6] 13.7± 2.8
overall 23/21 75.4±6.1 2.1 [1.0-4.1] 14.3± 2.8
pL NA 0.4224 NA 0.0001
pW NA 0.8202 NA 0.2101
II- Summary Statistics for Metric Distances at Baseline and Follow-up
Mean ± SD Min Q1 Median Q3 Max
Left-dbk (LDB) 3.40 ± 0.68 1.97 3.00 3.30 3.65 5.08
Left-dfk (LDF) 3.57 ± 0.77 2.26 2.99 3.48 4.02 6.03
Right-dbk(RDB) 3.65 ± 0.67 1.73 3.32 3.53 4.09 4.98
Right-dfk (RDF) 4.05 ± 0.67 2.96 3.72 3.95 4.34 5.71
III- Mean ± SD Values of Brain and Intracranial Volumes
BV1 BV3 ICV1 ICV3
CDR0 1006892± 104214.0 1003319.4± 101129.0 1407972 ± 156067.1 1464494± 177496.0
CDR0.5 1003850± 92293.4 993380.8 ± 95425.0 1408507± 134912.6 1454966± 138931.2
overall 1005647± 98408.2 999253.6 ± 97828.6 1408191± 146140.3 1460596± 161152.7
pL 0.2302 0.0079 0.0503 0.1070
pW 0.5192 0.3277 0.7929 0.8299
IV- Mean ± SD of Hippocampal Volumes
LB LF RB RF
CDR0 2081.4 ± 354.8 2081.4 ± 354.8 2081.4 ± 354.8 2081.4 ± 354.8
CDR0.5 1717.6 ± 224.8 1717.6 ± 224.8 1717.6 ± 224.8 1717.6 ± 224.8
overall 1932.6 ± 354.8 1932.6 ± 354.8 1932.6 ± 354.8 1932.6 ± 354.8
pL 0.3528 0.0268 0.2001 0.2359
pW 0.0003 < 0.0001 0.0149 0.0004
V- Mean ± SD of Metric Distances
LB LF RB RF
CDR0 3.34 ± 0.62 3.41 ± 0.54 3.63 ± 0.57 3.83 ± 0.47
CDR0.5 3.48 ± 0.76 3.82 ± 0.98 3.68 ± 0.81 4.37 ± 0.78
overall 3.40 ± 0.68 3.57 ± 0.77 3.65 ± 0.67 4.05 ± 0.67
pL 0.0498 0.4718 0.2891 0.1084
pW 0.5994 0.1590 0.9145 0.02058
Table 1: Summary information of subjects (I); summary statistics for metric distances at baseline and follow-
up, where SD stands for standard deviation, Q1 and Q3 stand for the first and third quartiles (II); means
and SDs of brain and intracranial volumes by diagnosis group (III); means and SDs of hippocampal volumes
by diagnosis group (IV); and means and SDs of metric distances by diagnosis group (V). pL: p-value based
on Lilliefor’s test of normality, pW : p-value based on Wilcoxon rank sum test. NA: not applicable; BV1
(BV3): brain volume at baseline (followup); ICV1(ICV3): intracranial volume at baseline (followup); LB: left
baseline; LF: left followup; RB: right baseline; and RF: right followup.
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Importance of Components
PC1 PC2 PC3 PC4
Prop. Var .9877 .0123 ∼ 0.0 ∼ 0.0
Cum. Prop .9877 ∼ 1.0 ∼ 1.0 1.0
Variable Loadings
PC1 PC2 PC3 PC4
HLV1 ∼ 0.0 ∼ 0.0 1.00 ∼ 0.0
HLM1 ∼ 0.0 ∼ 0.0 ∼ 0.0 1.00
BV1 .55 -.83 ∼ 0.0 ∼ 0.0
ICV1 .83 .55 ∼ 0.0 ∼ 0.0
Table 2: The importance of principal components and variable loadings from the principal component analysis
of metric distances and volumes of left hippocampi at baseline with eigenvalues based on the covariance matrix.
PCi stands for principal component i for i = 1, 2, 3, 4; Prop.Var: proportion of variance explained by the
principal components; Cum.Prop: cumulative proportion of the variance explained by the particular principal
component; HLV1: volume of left hippocampus at baseline; HLM1: metric distance of left hippocampus at
baseline; BV1: brain volume at baseline; ICV1: intracranial volume at baseline.
Baseline Followup
Importance of Components Importance of Components
PC1 PC2 PC3 PC4 PC1 PC2 PC3 PC4
Prop. Var .57 .27 .15 .01 .54 .32 .12 .02
Cum. Prop. .57 .84 .99 1.0 .54 .86 .98 1.0
Variable Loadings Variable Loadings
PC1 PC2 PC3 PC4 PC1 PC2 PC3 PC4
HLV .37 .59 .71 ∼ 0.0 .41 .55 .73 ∼ 0.0
HLM .22 -.80 .55 ∼ 0.0 ∼ 0.0 -.80 .60 ∼ 0.0
BV .64 ∼ 0.0 -.27 -.72 .65 -.16 -.18 -.72
ICV .63 ∼ 0.0 -.33 .70 .64 -.17 -.29 .69
Table 3: The importance of principal components and variable loadings from the principal component analysis
of metric distances and volumes of left hippocampi at baseline and followup with eigenvalues based on the
correlation matrix. HLV: volume of left hippocampus; HLM: metric distance of left hippocampus; BV: brain
volume; ICV: intracranial volume. The other abbreviations are as in Table 2.
Baseline Followup
Importance of Components Importance of Components
PC1 PC2 PC3 PC4 PC1 PC2 PC3 PC4
Prop. Var .54 .33 .12 .01 .57 .35 .07 .02
Cum. Prop. .54 .87 .99 1.0 .57 .92 .98 1.0
Variable Loadings Variable Loadings
PC1 PC2 PC3 PC4 PC1 PC2 PC3 PC4
HRV .35 .61 .71 ∼ 0.0 .50 .46 .72 .13
HRM ∼ 0.0 -.78 .62 ∼ 0.0 -.30 -.70 .64 ∼ 0.0
BV .66 ∼ 0.0 -.20 -.71 .58 -.37 ∼ 0.0 -.72
ICV .66 -.13 -.26 .70 .57 -.40 -.25 .67
Table 4: The importance of principal components and variable loadings from the principal component analysis
of metric distances and volumes of right hippocampi at baseline and followup with eigenvalues based on the
correlation matrix. HRV: volume of right hippocampus; HRM: metric distance of right hippocampus; BV:
brain volume; ICV: intracranial volume. The other abbreviations are as in Table 2.
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Compound Symmetry Unstructured

σ2
σ1 σ
2
σ1 σ1 σ
2
σ1 σ1 σ1 σ
2




σ21
σ21 σ
2
2
σ31 σ32 σ
2
3
σ41 σ42 σ43 σ
2
4


Autoregressive Autoregressive Hetero-
geneous Variances

σ2
σρ σ2
σρ2 σρ σ2
σρ3 σρ2 σρ σ2




σ21
σρ σ22
σρ2 σρ σ23
σρ3 σρ2 σρ σ24


Table 5: The Var-Cov structures for the repeated measures ANOVA analysis on the metric distances; σ2 is
the common variance term, σ2i is the variance for repeated factor i, σij is the covariance between repeated
factors i and j, and ρ is the correlation coefficient for first order in an autoregressive model.
Model Var-Cov df AIC BIC Log Likelihood Test L.Ratio p-value
1 CS 10 362.8 394.1 -171.4 — — —
2 UN 18 352.9 409.1 -158.4 1 vs 2 25.9 0.0011
3 ARH 13 350.9 391.5 -162.5 1 vs 3 17.92 < 0.0001
4 AR 10 347.1 378.4 -163.6 — — —
Table 6: Model selection criteria results for models with compound symmetry (CS), unstructured (US),
autoregressive (AR), and autoregressive heterogeneous (ARH) Var-Cov structures. df = error degree of
freedom, AIC = Akaike information criteria, BIC = Bayesian information criteria, L.Ratio = likelihood ratio.
Independent Group Comparisons of LDDMM Distances
p-values for t-test p-values for Wilcoxon test
Groups 2-sided 1st < 2nd 1st > 2nd 2-sided 1st < 2nd 1st > 2nd
LB-CDR0.5,LB-CDR0 .5362 .7319 .2681 .6078 .7044 .3039
LF-CDR0.5,LF-CDR0 .1179 .9410 .0590 .1625 .9223 .0813
RB-CDR0.5,RB-CDR0 .8176 .5912 .4088 .9239 .5475 .462
RF-CDR0.5,RF-CDR0 .0148* .9926 .0074* .0212* .99 .0106*
Dependent Group Comparisons of LDDMM Distances
p-values for paired t-test p-values for paired Wilcoxon test
Groups 2-sided 1st < 2nd 1st > 2nd 2-sided 1st < 2nd 1st > 2nd
LB-CDR0.5,LF-CDR0.5 .0259* .0129* .9871 .0311* .0155* .9861
RB-CDR0.5,RF-CDR0.5 .0002* .0001* .9999 .0005* .0002* .9998
LB-CDR0,LF-CDR0 .5958 .2979 .7021 .7127 .3563 .6531
RB-CDR0,RF-CDR0 .1241 .0621 .9379 .1244 .0622 .9409
Table 7: The p-values based on independent sample t-test (top) and Wilcoxon rank sum test (middle) for both
left and right metric distances and p-values based on paired t-tests for both left and right metric distances
(bottom). Notice that we use t-tests when the assumptions (such as normality or homogeneity of variances
hold), otherwise we use Wilcoxon test. Significant p-values at 0.05 level are marked with an asterisk (*).
Correlation Coefficients of Baseline vs Follow-up Distances
Groups rP ρS τK
LDB,LDF .6642 (<.0001*) .5686 (<.0001*) .3843 (.0001*)
RDB,RDF .5076 (.0002*) .3835 (.0053*) .2754 (.0042*)
LB-CDR0.5,LF-CDR0.5 .7988 (<.0001*) .8147 (<.0001*) .6164 (.0002*)
RB-CDR0,RF-CDR0.5 .6995 (.0006*) .7028 (.0008*) .5556 (.0004*)
LB-CDR0,LF-CDR0 .4929 (.0053*) .3455 (.0420*) .2102 (.0661)
RB-CDR0,RF-CDR0 .2812 (.0820) .1888 (.1767) .1418 (.1549)
Table 8: The correlation coefficients and the associated p-values for the one-sided (correlation greater than
zero) alternatives. rP = Pearson’s correlation coefficient, ρS = Spearman’s rank correlation coefficient, and
τK = Kendall’s rank correlation coefficient. Significant p-values at 0.05 level are marked with an asterisk (*).
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Correlation Coefficients of Distances of Left vs Right Hippocampi
Groups rP ρS τK
LDB,RDB .4017 (.0034*) .27 (.0382*) .1749 (.0471*)
LDF,RDF .3441 (.0111*) .2009 (.0952) .1241 (.1175)
LB-CDR0.5,RB-CDR0 .3312 (.0492*) .3813 (.0277*) .2191 (.0582)
LF-CDR0.5,RF-CDR0.5 .1033 (.3078) .0400 (.4225) .0340 (.4039)
LB-CDR0,RB-CDR0 .3312 (.0492*) .3813 (.0277*) .2191 (.0582)
LF-CDR0,RF-CDR0 .1033 (.3078) .0400 (.4225) .0340 (.4039)
Table 9: The correlation coefficients and the associated p-values for the one-sided (correlation greater than
zero) alternatives. rP , ρS , and τK stand for Pearson’s, Spearman’s, and Kendall’s correlation coefficients,
respectively. Significant p-values at 0.05 level are marked with an asterisk (*).
p-values for cdf comparisons of Distances
Groups pKS (2-s) pKS (l) pKS (g) pC pCvM
LB-CDR0.5,LB-CDR0 .6932 .364 .5706 .4325 .5112
RB-CDR0,RB-CDR0 .8997 .5204 .5875 .6684 .7098
LF-CDR0.5,LF-CDR0 .1208 .0604 .5706 .0495* .0665
RF-CDR0.5,RF-CDR0 .0517* .0259* .9365 .0095* .0235*
Table 10: The p-values for the K-S, Crame´r’s, and Crame´r-von Mises tests. pKS (2-s), pKS (l), and pKS (g)
stand for the p-values based on K-S test for the two sided alternative, first cdf less than the second, and first
cdf greater than the second alternatives, respectively, pC , and pCvM stands for the p-values for Crame´r’s test
and Crame´r-von Mises test, respectively. Significant p-values at 0.05 level are marked with an asterisk (*).
A Truth
Predict
CDR0 CDR0.5 Total
CDR0 95 52 147
CDR0.5 9 20 29
Total 104 72 176
B Truth
Predict
CDR0 CDR0.5 Total
CDR0 18 8 26
CDR0.5 8 10 18
Total 26 18 44
C Truth
Predict
CDR0 CDR0.5 Total
CDR0 22 8 30
CDR0.5 4 10 14
Total 26 18 44
D Truth
Predict
CDR0 CDR0.5 Total
CDR0 22 10 32
CDR0.5 4 8 12
Total 26 18 44
Table 11: The classification matrices using metric distances in logistic regression with threshold p = 0.5: A
= classification matrix of all hippocampi using logistic model MII(D) using hippocampal LDDMM metric
distances in Equation (9); B = classification matrix of subjects using logistic model MII(D) in Equation (9)
with one hippocampus MRI classified as CDR0.5 being sufficient to label CDR0.5; C = classification matrix of
subjects using logistic model MIII(D) in Equation (10) that only uses follow-up hippocampus MRIs and one
hippocampus sufficient to label CDR0.5; D = classification matrix of subjects using logistic model MIV (D)
in Equation (11) that only uses follow-up right hippocampus MRIs.
A B C∗ D
PCCR 65% 64% 73% 68%
Psens 28% 56% 56% 44%
Pspec 91% 69% 85% 85%
Table 12: The correct classification rates (PCCR), sensitivity (Psens), and specificity (Pspec) percentages
with po = 0.50 for the classification procedures A-D in Table 11. The model with the best classification
performance is marked with an asterisk (∗).
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po = 1/2 po = 18/44
MI(D) MII(D) MIII(D)
∗ MIV (D) MI(D) MII(D) MIII(D) MIV (D)∗
PCCR 66% 64% 73% 68% 57% 47% 66% 68%
Psens 56% 56% 56% 44% 83% 67% 67% 61%
Pspec 73% 69% 85% 85% 38% 35% 65% 73%
Using optimum po based on cost function C1(po, w1, w2) with
w1 = w2 = 1 w1 = 1, w2 = 3
MI(D) MII(D) MIII(D) MIV (D)
∗ MI(D) MII(D) MIII(D) MIV (D)∗
popt .51 .50 .45 .38 .51 .47 .36,.37 .38
PCCR 68% 64% 70% 70% 68% 57% 68% 70%
Psens 56% 56% 67% 72% 56% 61% 78% 72%
Pspec 77% 69% 73% 69% 77% 54% 61% 69%
Using optimum po based on cost function C2(po) with
η1 = η2 = 0.5 η1 = .3, η2 = 0.7
MI(D) MII(D) MIII(D) MIV (D)
∗ MI(D) MII(D) MIII(D)∗ MIV (D)
popt .81-.82 .76-.78 .50-.52 .38 .37 .37 .33-.34 .22-.29
PCCR 75% 73% 73% 70% 59% 61% 66% 55%
Psens 39% 39% 56% 72% 95% 100% 89% 89%
Pspec 100% 96% 85% 69% 35% 35% 50% 31%
Table 13: The correct classification rates (PCCR), sensitivity (Psens), and specificity (Pspec) percentages for
the classification procedures based on models MI(D) −MIV (D) using hippocampal LDDMM metrics and
volumes with threshold probabilities po = 1/2 and po = 18/44 (top); with optimum threshold values po = popt
based on the cost function C1(po, w1, w2) with w1 = w2 = 1 and w1 = 1, w2 = 3 (middle); and with optimum
threshold values po = popt based on the cost function C2(po, η1, η2) with η1 = η2 = 0.5 and η1 = .3, η2 = 0.7
(bottom). The model with the best classification performance is marked with an asterisk (∗).
Volume comparisons p-values for t-test p-values for Wilcoxon test
Groups 2-sided 1st < 2nd 1st > 2nd 2-sided 1st < 2nd 1st > 2nd
LB-CDR0.5,LB-CDR0 .0002∗ .0001∗ .9999 .0002∗ .0001∗ .9999
LF-CDR0.5,LF-CDR0 < .0001∗ < .0001∗ ≈ 1.000 < .0001∗ < .0001∗ ≈ 1.000
RB-CDR0.5,RB-CDR0 .0025∗ .0012∗ .9998 .0143∗ .0071∗ .9933
RF-CDR0.5,RF-CDR0 .0001∗ < .0001∗ ≈ 1.000 .0002∗ .0001∗ .9999
p-values for paired t-test paired Wilcoxon test
Groups 2-sided 1st < 2nd 1st > 2nd 2-sided 1st < 2nd 1st > 2nd
LB-CDR0.5,LF-CDR0.5 < .0001∗ ≈ 1.000 < .0001∗ .0001∗ ≈ 1.000 < .0001∗
RB-CDR0.5,RF-CDR0.5 < .0001∗ ≈ 1.000 < .0001∗ < .0001∗ ≈ 1.000 < .0001∗
LB-CDR0,LF-CDR0 < .0001∗ ≈ 1.000 < .0001∗ .0001∗ .9999 < .0001∗
RB-CDR0,RF-CDR0 < .0001∗ .9999 .0001∗ .0002∗ .9999 .0001∗
LB-CDR0.5,RB-CDR0.5 < .0001∗ < .0001∗ ≈ 1.000 < .0001∗ < .0001∗ ≈ 1.000
LF-CDR0.5,RF-CDR0.5 < .0001∗ < .0001∗ ≈ 1.000 .0001∗ .0001∗ ≈ 1.000
LB-CDR0,RB-CDR0 < .0001∗ < .0001∗ ≈ 1.000 < .0001∗ < .0001∗ ≈ 1.000
LF-CDR0,RF-CDR0 < .0001∗ < .0001∗ ≈ 1.000 < .0001∗ < .0001∗ ≈ 1.000
Table 14: The p-values based on independent sample t-test (top) and Wilcoxon rank sum test (middle)
for both left and right hippocampus volumes and p-values based on paired t-tests for both left and right
hippocampus volumes (bottom). Significant p-values at 0.05 level are marked with an asterisk (*).
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po = 1/2 po = 18/44
MI(V ) MII(V ) MIII(V )
∗ MIV (V ) MI(V ) MII(V ) MIII(V ) MIV (V )∗
PCCR 68% 70% 73% 80% 70% 68% 64% 78%
Psens 83% 89% 83% 72% 89% 89% 100% 78%
Pspec 58% 58% 65% 85% 58% 54% 38% 77%
Using optimum po based on cost function C1(po, w1, w2) with
w1 = w2 = 1 w1 = 1, w2 = 3
MI(V ) MII(V ) MIII(V ) MIV (V )
∗ MI(V ) MII(V ) MIII(V ) MIV (V )∗
popt .64-.66 .62-.63 .55-.58 .35-.42 .61-.62 .58-.60 .55-.58 .35-.36
PCCR 82% 75% 77% 80% 80% 73% 77% 80%
Psens 78% 78% 83% 89% 83% 83% 83% 89%
Pspec 85% 73% 73% 73% 77% 65% 73% 73%
Using optimum po based on cost function C2(po, η1, η2) with
η1 = η2 = 0.5 η1 = .3, η2 = 0.7
MI(V ) MII(V ) MIII(V ) MIV (V )
∗ MI(V ) MII(V ) MIII(V ) MIV (V )∗
popt .64-.66 .70 .69 .35-.36 .31 .31 .25-.32 .26
PCCR 82% 80% 82% 80% 70% 66% 70% 77%
Psens 78% 61% 61% 89% 100% 100% 94% 94%
Pspec 85% 92% 96% 73% 50% 42% 54% 65%
Table 15: The correct classification rates (PCCR), sensitivity (Psens), and specificity (Pspec) percentages
for the classification procedures based on models MI(V )−MIV (V ) using hippocampal LDDMM metrics and
volumes with threshold probabilities po = 1/2 and po = 18/44 (top); with optimum threshold values po = popt
based on the cost function C1(po, w1, w2) with w1 = w2 = 1 and w1 = 1, w2 = 3 (middle); and with optimum
threshold values po = popt based on the cost function C2(po, η1, η2) with η1 = η2 = 0.5 and η1 = .3, η2 = 0.7
(bottom). The model with the best classification performance is marked with an asterisk (∗).
po = 1/2 po = 18/44
MI(V,D) MII(V,D) MIII(V,D) MIV (V,D)
∗ MI(V,D) MII(V,D) MIII(V,D) MIV (V,D)∗
PCCR 75% 66% 75% 82% 66% 66% 73% 77%
Psens 89% 89% 83% 78% 89% 89% 89% 83%
Pspec 65% 50% 69% 85% 50% 50% 62% 73%
Using optimum po based on cost function C1(po, w1, w2) with
w1 = w2 = 1 w1 = 1, w2 = 3
MI(V,D)
∗ MII(V,D) MIII(V,D) MIV (V,D) MI(V,D)∗ MII(V,D) MIII(V,D) MIV (V,D)
popt .64-.65 .66 .48-.58 .48 .64-.65 .66 .48-.54 .28-.33
PCCR 84% 84% 75% 84% 84% 84% 75% 80%
Psens 89% 83% 83% 83% 89% 83% 83% 89%
Pspec 81% 85% 69% 85% 81% 85% 69% 73%
Using optimum po based on cost function C2(po, η1, η2) with
η1 = η2 = 0.5 η1 = .3, η2 = 0.7
MI(V,D)
∗ MII(V,D) MIII(V,D) MIV (V,D) MI(V,D)∗ MII(V,D) MIII(V,D) MIV (V,D)
popt .64-.65 .66 .68-.72 .48 .64-.65 .66 .23 .20-.22
PCCR 84% 84% 80% 84% 84% 84% 70% 75%
Psens 89% 83% 61% 83% 89% 83% 100% 94%
Pspec 81% 85% 92% 85% 81% 85% 50% 61%
Table 16: The correct classification rates (PCCR), sensitivity (Psens), and specificity (Pspec) percentages for
the classification procedures based on models MI(V,D) −MIV (V,D) using hippocampal LDDMM metrics
and volumes with threshold probabilities po = 1/2 and po = 18/44 (top); with optimum threshold values
po = popt based on the cost function C1(po, w1, w2) with w1 = w2 = 1 and w1 = 1, w2 = 3 (middle); and
with optimum threshold values po = popt based on the cost function C2(po, η1, η2) with η1 = η2 = 0.5 and
η1 = .3, η2 = 0.7 (bottom). The model with the best classification performance is marked with an asterisk
(∗).
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po = 1/2 po = 18/44
MI
(
V APC
)∗
MII
(
V APC
)
MIII
(
V APC
)
MI
(
V APC
)
MII
(
V APC
)
MIII
(
V APC
)
PCCR 75% 80% 75% 64% 73% 73%
Psens 72% 61% 61% 83% 61% 61%
Pspec 77% 92% 85% 50% 81% 81%
Using optimum po based on cost function C1(po, w1, w2) with
w1 = w2 = 1 w1 = 1, w2 = 3
MI
(
V APC
)∗
MII
(
V APC
)
MIII
(
V APC
)
MI
(
V APC
)∗
MII
(
V APC
)
MIII
(
V APC
)
popt .55-.55 .38-.39 .27-.28 .54-.55 .34 .25
PCCR 80% 75% 75% 80% 73% 73%
Psens 72% 72% 78% 72% 83% 83%
Pspec 85% 81% 73% 85% 65% 65%
Using optimum po based on cost function C2(po, η1, η2) with
η1 = η2 = 0.5 η1 = .3, η2 = 0.7
MI
(
V APC
)∗
MII
(
V APC
)
MIII
(
V APC
)
MI
(
V APC
)
MII
(
V APC
)
MIII
(
V APC
)
popt .54-.55 .82-.85 .61-.69 .39 .34 .18-.21
PCCR 80% 82% 82% 64% 73% 70%
Psens 72% 56% 56% 89% 83% 100%
Pspec 85% 100% 100% 46% 65% 50%
Table 17: The correct classification rates (PCCR), sensitivity (Psens), and specificity (Pspec) percentages for
the classification procedures based on modelsMI
(
V APC
)
−MIII
(
V APC
)
using APC in hippocampal volumes
with threshold probabilities po = 1/2 and po = 18/44 (top); with optimum threshold values po = popt based
on the cost function C1(po, w1, w2) with w1 = w2 = 1 and w1 = 1, w2 = 3 (middle); and with optimum
threshold values po = popt based on the cost function C2(po, η1, η2) with η1 = η2 = 0.5 and η1 = .3, η2 = 0.7
(bottom). The model with the best classification performance is marked with an asterisk (∗).
po = 1/2 po = 18/44
MI
(
DAPC
)
MII
(
DAPC
)
MIII
(
DAPC
)
MI
(
DAPC
)
MII
(
DAPC
)∗
MIII
(
DAPC
)
PCCR 59% 61% 61% 57% 77% 64%
Psens 27% 28% 28% 72% 72% 56%
Pspec 81% 85% 85% 46% 42% 69%
Using optimum po based on cost function C1(po, w1, w2) with
w1 = w2 = 1 w1 = 1, w2 = 3
MI
(
DAPC
)∗
MII
(
DAPC
)∗
MIII
(
DAPC
)
MI
(
DAPC
)
MII
(
DAPC
)
MIII
(
DAPC
)
popt .45 .45-.46 .41 .42 .45-.46 .36
PCCR 66% 66% 66% 61% 66% 64%
Psens 61% 61% 56% 67% 61% 78%
Pspec 69% 69% 73% 58% 69% 54%
Using optimum po based on cost function C2(po, η1, η2) with
η1 = η2 = 0.5 η1 = .3, η2 = 0.7
MI
(
DAPC
)
MII
(
DAPC
)
MIII
(
DAPC
)∗
MI
(
DAPC
)
MII
(
DAPC
)
MIII
(
DAPC
)
popt .45 .45-.46 .32 .37 .35-.36 .29
PCCR 66% 66% 64% 52% 55% 59%
Psens 61% 61% 89% 100% 100% 100%
Pspec 69% 69% 46% 19% 23% 31%
Table 18: The correct classification rates (PCCR), sensitivity (Psens), and specificity (Pspec) percentages for
the classification procedures based on models MI
(
DAPC
)
−MIII
(
DAPC
)
using APC in hippocampal LD-
DMM metric distances with threshold probabilities po = 1/2 and po = 18/44 (top); with optimum threshold
values po = popt based on the cost function C1(po, w1, w2) with w1 = w2 = 1 and w1 = 1, w2 = 3 (middle);
and with optimum threshold values po = popt based on the cost function C2(po, η1, η2) with η1 = η2 = 0.5 and
η1 = .3, η2 = 0.7 (bottom). The model with the best classification performance is marked with an asterisk
(∗).
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po = 1/2 po = 18/44
MI
(
V APC , D
)
MII
(
V APC , D
)
MIII
(
V APC , D
)
MI
(
V APC , D
)
MII
(
V APC , D
)
MIII
(
V APC , D
)∗
PCCR 73% 77% 77% 68% 75% 80%
Psens 83% 67% 56% 83% 72% 87%
Pspec 65% 85% 92% 58% 77% 85%
Using optimum po based on cost function C1(po, w1, w2)with
w1 = w2 = 1 w1 = 1, w2 = 3
MI
(
V APC , D
)
MII
(
V APC , D
)
MIII
(
V APC , D
)∗
MI
(
V APC , D
)∗
MII
(
V APC , D
)
MIII
(
V APC , D
)
popt .61 .53-.73 .35-.40 .56 .35-.36 .31-.32
PCCR 84% 82% 80% 80% 70% 75%
Psens 72% 67% 78% 78% 78% 83%
Pspec 92% 92% 81% 81% 65% 69%
Using optimum po based on cost function C2(po, η1, η2) with
η1 = η2 = .5 η1 = .3, η2 = .7
MI
(
V APC , D
)
MII
(
V APC , D
)
MIII
(
V APC , D
)
MI
(
V APC , D
)∗
MII
(
V APC , D
)
MIII
(
V APC , D
)
popt .61 .53-.73 .49 .56 .23-.25 .31-.32
PCCR 84% 82% 82% 80% 55% 75%
Psens 72% 67% 67% 78% 100% 83%
Pspec 92% 92% 92% 81% 23% 69%
Table 19: The correct classification rates (PCCR), sensitivity (Psens), and specificity (Pspec) percentages for the classification procedures based on models
MI
(
V APC , D
)
−MIII
(
V APC , D
)
using metric distance, and APC in hippocampal volumes with threshold probabilities po = 1/2 and po = 18/44 (top);
with optimum threshold values po = popt based on the cost function C1(po, w1, w2) with w1 = w2 = 1 and w1 = 1, w2 = 3 (middle); and with optimum
threshold values po = popt based on the cost function C2(po, η1, η2) with η1 = η2 = 0.5 and η1 = .3, η2 = 0.7 (bottom). The model with the best classification
performance is marked with an asterisk (∗).
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3
po = 1/2 po = 18/44
MI
(
V, V APC , D
)
MII
(
V, V APC , D
)∗
MIII
(
V, V APC , D
)∗
MI
(
V, V APC , D
)
MII
(
V, V APC , D
)
MIII
(
V, V APC , D
)∗
PCCR 86% 89% 89% 80% 80% 91%
Psens 94% 89% 89% 94% 94% 94%
Pspec 81% 88% 88% 69% 69% 88%
Using optimum po based on cost function C1(po, w1, w2)with
w1 = w2 = 1 w1 = 1, w2 = 3
MI
(
V, V APC , D
)
MII
(
V, V APC , D
)
MIII
(
V, V APC , D
)∗
MI
(
V, V APC , D
)
MII
(
V, V APC , D
)
MIII
(
V, V APC , D
)∗
popt .56-.57 .48-.51 .39-.42 .56-.57 .48-.51 .39-.42
PCCR 89% 89% 91% 89% 89% 91%
Psens 94% 89% 94% 94% 89% 94%
Pspec 85% 88% 88% 85% 88% 88%
Using optimum po based on cost function C2(po, η1, η2) with
η1 = η2 = .5 η1 = .3, η2 = .7
MI
(
V, V APC , D
)
MII
(
V, V APC , D
)
MIII
(
V, V APC , D
)∗
MI
(
V, V APC , D
)
MII
(
V, V APC , D
)
MIII
(
V, V APC , D
)∗
popt .56-.57 .48-.51 .39-.42 .56-.57 .48-.51 .39-.42
PCCR 89% 89% 91% 89% 89% 91%
Psens 94% 89% 94% 94% 89% 94%
Pspec 85% 88% 88% 85% 88% 88%
Table 20: The correct classification rates (PCCR), sensitivity (Psens), and specificity (Pspec) percentages for the classification procedures based on models
MI
(
V, V APC , D
)
−MIII
(
V, V APC , D
)
using metric distance, and APC in hippocampal volumes with threshold probabilities po = 1/2 and po = 18/44 (top);
with optimum threshold values po = popt based on the cost function C1(po, w1, w2) with w1 = w2 = 1 and w1 = 1, w2 = 3 (middle); and with optimum
threshold values po = popt based on the cost function C2(po, η1, η2) with η1 = η2 = 0.5 and η1 = .3, η2 = 0.7 (bottom). The model with the best classification
performance is marked with an asterisk (∗).
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4
Figure 1: Change in metric distance during diffeomorphic flow from template (I0) to target (I1 = φ1I0 =
I0 ◦ φ
−1
1 ).
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Figure 2: Generation of metric distances d
{b,f}
k for subjects k = 1, . . . , 44 at baseline (b) and at follow-up
(f).
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Figure 3: Pairs plots of the continuous variables for the hippocampi at baseline and follow-up. HLV: volume
of left hippocampus; HRV: volume of right hippocampus; HLM: metric distance for left hippocampus; HRM:
metric distance for right hippocampus; BV: brain volume; ICV: intracranial volume. The numbers 1 and 3
stand for year 1 (i.e., baseline) and year 3 (i.e., follow-up), respectively.
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Figure 4: Scatter plots of the metric distances for the left and right distances at baseline and follow-up. The
metric distances are jittered for better visualization and the crosses represent the mean distance values.
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Figure 5: The left interaction plot is for diagnosis levels over the timepoint levels (the effect of sides is
ignored). The slope (i.e., the rate of change in morphometry for CDR0.5 subjects) is significantly larger
than that of CDR0 subjects. The right interaction plot for side levels over the timepoint levels (the effect of
diagnosis is ignored). The slopes seem to not significantly differ between Left and Right hippocampi.
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Figure 6: Interaction plots for diagnosis levels over the timepoint levels for left and right metric distances.
Although the slopes are different for both left and right hippocampi, the difference in the right seems to be
much larger.
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Figure 7: Empirical cdfs of the metric distances for the CDR0.5 vs CDR0 Left and Right hippocampus at
follow-up.
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Figure 8: Fitted probability for having mild dementia (CDR0.5) and observed proportion in metric distances
with model (9) (top-left); model (10) (top-right); and model (11) (bottom),
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